Curriculum Vitae

PROF. DR. LIM SOO KUN

Professor
  • Department of Medicine
    Faculty of Medicine
  • sookunlim
  • 0379492747

ACADEMIC QUALIFICATION

  • MRCP(UK), (Medicine and Surgery)
    Royal College of Physicians of Edinburgh, United Kingdom
  • MBBS(UM)(1999), (PERUBATAN DAN PEMBEDAHAN)
    Universiti Malaya (UM)

ADMINISTRATIVE DUTIES

  • Head of Unit
    20 Oct 2022 - 24 Oct 2024 (Department)
  • Coordinator
    01 Jul 2022 - 30 Jun 2024 (Faculty)
  • Committee Members
    27 Oct 2022 - 27 Oct 2023 (Department of Medicine, Faculty of Medicine)
  • Curriculum Committee, UMMC Renal Post-Basic Nursing
    02 Mar 2021 - 01 Mar 2023 (Department of Medicine, Faculty of Medicine)
  • COMMITTEE MEMBER (TREASURER) OF UMSC DEPARTMENT FUND
    04 Nov 2020 - 04 Nov 2022 (Department of Medicine, Faculty of Medicine)
  • THEME COORDINATOR FOR UMMP
    01 Jul 2013 - 30 Jun 2022 (Department of Medicine, Faculty of Medicine)
  • Department Representative for Drug Therapeutic Committee (DTC)
    01 Jan 2017 - 31 Dec 2021 (Department of Medicine, Faculty of Medicine)
  • Medical Advisory Committee (Department Representative)
    22 Jan 2019 - 31 Dec 2021 (Department of Medicine, Faculty of Medicine)
  • Head of Unit
    08 Feb 2019 - 08 Feb 2021 (Department of Medicine, Faculty of Medicine)
  • Deputy HOD Department of Medicine
    01 Mar 2019 - 07 Feb 2021 (Department of Medicine, Faculty of Medicine)
  • Committee member of Organ Transplant Committee (OTC)
    01 Mar 2012 - 31 Dec 2020 (Department of Medicine, Faculty of Medicine)
  • Committee member of Blood Transfusion Committee
    15 Mar 2012 - 31 Dec 2020 (Department of Medicine, Faculty of Medicine)
  • Problem Based Learning (PBL) Committee member
    02 Aug 2011 - 01 Aug 2015 (Faculty)
  • UMMC Electronic Medical Record(eMR) Clinical Champion
    01 Oct 2013 - 30 Sep 2014 (University Malaya)
  • Head, Division of Nephrology, Department of Medicine, Faculty of Medicine
    29 Dec 2009 - 31 Dec 2013 (Department of Medicine, Faculty of Medicine)
  • Phase 3A Coordinator for PBL
    26 Apr 2011 - 25 Apr 2013 (Faculty)
  • Question Vetting Committee member for Master of Medicine Part 2
    23 Aug 2010 - 31 Dec 2012 (Department of Medicine, Faculty of Medicine)
  • Department Coordinator for Biomedical Engineering Course
    14 May 2010 - 14 May 2011 (Department of Medicine, Faculty of Medicine)
  • Coordinator for Problem-based Learning (PBL) for Department of Medicine
    01 Jan 2008 - 04 Oct 2010 (Department of Medicine, Faculty of Medicine)

MEMBERSHIPS

  • EDITORIAL ADVISORY COMMITTEE (EAC) FOR RENAL OUTLOOK AS A GUEST SUBJECT EDITOR, EDITORIAL BOARD
    2024 to present (International)
  • PRESIDENT OF MALAYSIAN SOCIETY OF NEPHROLOGY, PRESIDENT/ CHIEF
    Since 2024 (National)
  • AHLI SUBSPECIALTY SUBCOMMITTEE FOR EDUCATION (SBSC-EDU} BAGI BIDANG NEPHROLOGY, COMMITTEE MEMBER
    2024 to present (National)
  • JAWATANKUASA KERJA UBAT-UBATAN (JKKU), KKM, COMMITTEE MEMBER
    2024 to 2025 (National)
  • MALAYSIAN ASSOCIATION OF CLINICAL BIOCHEMISTS-CHRONIC KIDNEY DISEASE (MACB-CKD) TASKFORCE, COMMITTEE MEMBER
    2024 to present (National)
  • SUBJECT EDITOR OF NEPHROLOGY JOURNAL, EDITORIAL BOARD
    2024 to present (International)
  • NATIONAL STRATEGIC ACTION PLAN FOR KIDNEY HEALTH (ACT-KID) 2026-2030, COMMITTEE MEMBER
    2023 to present (National)
  • JOURNAL OF NEPHROLOGY, EDITORIAL BOARD
    2021 to present (International)
  • MALAYSIA ADPKD ADVISORY BOARD MEETING, ADVISORY BOARD
    2024 to 2024 (National)
  • MALAYSIAN SOCIETY FOR QUALITY IN HEALTH (MSQH) MEDICAL TEAM CHAIR, COMMITTEE MEMBER
    2023 to 2024 (University)
  • AHLI JAWANTANKUASA KECIL PENILAIAN KEPAKARAN PERUBATAN (JKKPKP) BIDANG NEFROLOGI, COMMITTEE MEMBER
    2023 to 2024 (National)
  • MALAYSIAN SOCIETY OF NEPHROLOGY RESEARCH GRANT COMMITTEE 2022 - 2024, PRESIDENT/ CHIEF
    2022 to 2024 (National)
  • NATIONAL KIDNEY FOUNDATION (NKF) BOARD MEMBER, BOARD MEMBER
    2022 to 2024 (National)
  • VICE PRESIDENT MALAYSIAN SOCIETY OF NEPHROLOGY, VICE PRESIDENT
    2022 to 2024 (National)
  • JOURNAL OF CLINICAL AND TRANSLATIONAL NEPHROLOGY (JCTN), EDITORIAL BOARD
    2019 to 2024 (National)
  • MALAYSIA SOCIETY OF TRANSPLANTATION (MST) COUNCIL MEMBER, COMMITTEE MEMBER
    2020 to 2022 (National)
  • MALAYSIA SOCIETY OF NEPHROLOGY (MSN) COUNCIL MEMBER, COMMITTEE MEMBER
    2020 to 2022 (National)

AWARD AND STEWARDSHIP

  • CRM Sponsored Research Award "Investigator of the Year" 2021
    Clinical Research Malaysia (CRM), 2021 (National)
  • EXCELLENCE SERVICE AWARD
    University of Malaya, 2020 (University)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2017 (University)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2016 (University)
  • EXCELLENCE SERVICE AWARD
    University of Malaya, 2015 (University)
  • EXCELLENCE SERVICE AWARD
    University of Malaya, 2012 (University)
  • Best Abstract Award at 14th Congress of the International Society for Peritoneal Dialysis (ISPD)(First Prize)
    International Society for Peritoneal Dialysis (ISPD) & Malaysian Society of Nephrology, 2012 (International)
  • Travel Grant form Congress of Asian-Pacific Society of Transplantation
    Congress of Asian-Pacific Society of Transplantation, 2011 (International)
  • Best Abstract (Second Prize)
    Malaysian Society of Transplantation (MST), 2010 (National)
  • Best Absracts (Third prize)
    Malaysian Society of Nephrology, 2007 (National)

PUBLICATIONS

Article in Journal
WoS
  1. Lim, Soo Kun; Lee, Shaun Wen Huey (2024). Cost-effectiveness analysis of dapagliflozin for people with chronic kidney disease in Malaysia, PLOS ONE. 19(3). doi:10.1371/journal.pone.0296067
  2. Ng, Ka Ting; Lim, Wei En; Teoh, Wan Yi; Lim, Soo Kun; bin Fadzli, Ahmad Nazran; San Loh, Pui (2024). Effects of perioperative dexmedetomidine on delayed graft function following renal transplant: a systematic review and meta-analysis, BRAZILIAN JOURNAL OF ANESTHESIOLOGY. 74(6). doi:10.1016/j.bjane.2024.844534
  3. Wong, Zhi Yong; Teo, Chiu Yee; Wong, Yan Qi Fiona; Ng, Ka Ting; Lim, Soo Kun (2024). Immunosuppression for adult steroid-dependent or frequently relapsing nephrotic syndrome: A systematic review and meta-analysis, PLOS ONE. 19(7). doi:10.1371/journal.pone.0307981
  4. Chew, Chang Chuan; Jalalonmuhali, Maisarah; Lim, Soo Kun; Cheng, Shian Feng; Lee, Yee Wan; Wong, Albert Hing; Ooi, Shok Hoon; Raziana, Razi Nur; Ng, Kok Peng (2023). AN ANALYSIS OF ARTERIO-VENOUS FISTULA AND NT-PRO BNP AFTER KIDNEY TRANSPLANTATION, NEPHROLOGY. 28, 56-56
  5. Heerspink, Hiddo Lambers; Barratt, Jonathan; Gorriz Teruel, Jose Luis; Kotwal, Sradha; Lim, Soo Kun; Noronha, Irene L.; Beckett, Valeria; Camargo, Marianne; Jones-Burton, Charlotte; King, Andrew; Mottl, Amy K. (2023). ASSIST STUDY DESIGN: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER STUDY OF ATRASENTAN IN PATIENTS WITH IGA NEPHROPATHY (IGAN) ON SGLT2I, NEPHROLOGY DIALYSIS TRANSPLANTATION. 38, I397-I397
  6. Sharafaldin, Esra Nasraldin Khalil; Huri, Hasniza Zaman; Sim, Maw Shin; Lim, Soo Kun (2023). Potential immunological and genetic markers associated with lupus nephritis: From pathogenicity to therapeutic drug target, AUTOIMMUNITY REVIEWS. 22(12). doi:10.1016/j.autrev.2023.103406
  7. Thye, Chee Keong; Lee, Yee Wan; Jalalonmuhali, Maisarah; Lim, Soo Kun; Ng, Kok Peng (2023). Creatinine clearance in selection of living kidney donor among the Malaysian population: is it safe?, BMC NEPHROLOGY. 24(1). doi:10.1186/s12882-023-03057-w
  8. Wong, Wei-Kei; Chan, Wah-Kheong; Ganapathy, Shubash Shander; Lim, Soo-Kun (2023). Metabolic dysfunction-associated fatty liver disease (MAFLD) and advanced liver fibrosis among hemodialysis patients in a multiethnic urban population in Malaysia, SEMINARS IN DIALYSIS. . doi:10.1111/sdi.13117
  9. Yugavathy, Nava; Abdullah, Bashar Mudhaffar; Lim, Soo Kun; Gafor, Abdul Halim Bin Abdul; Wong, Muh Geot; Bavanandan, Sunita; Wong, Hin Seng; Huri, Hasniza Zaman (2023). Precision Medicine in Erythropoietin Deficiency and Treatment Resistance: A Novel Approach to Management of Anaemia in Chronic Kidney Disease, CURRENT ISSUES IN MOLECULAR BIOLOGY. 45(8), 6550-6563. doi:10.3390/cimb45080413
  10. Abdullah, Elisya Liyana; Jalalonmuhali, Maisarah; Ng, Kok Peng; Jamaluddin, Farhi Ain; Lim, Soo Kun (2022). The Role of Lymphocyte Subset in Predicting Allograft Rejections in Kidney Transplant Recipients, TRANSPLANTATION PROCEEDINGS. 54(2), 312-319. doi:10.1016/j.transproceed.2022.01.009
  11. Chia, Yook Chin; Ahmad, Wan Azman Wan; Fong, Alan Yean Yip; Rosman, Azhari; Rahman, Abdul Rashid Abdul; Choo, Gim Hooi; Lim, Soo Kun; Abu Bakar, Mohammad Zawawi; Ong, Tiong Kiam (2022). 2022 Malaysian Working Group Consensus Statement on Renal Denervation for management of arterial hypertension, HYPERTENSION RESEARCH. . doi:10.1038/s41440-022-00937-w
  12. Goh, En Thong; Gan, Chye Chung; Lim, Soo Kun; Wong, Chew Ming; Lee, Yee Wan; Chew, Chang Chuan; Jalalonmuhali, Maisarah (2022).

    Metabolic Changes In Living Kidney Donors After Donation In University Malaya Medical Centre

    , TRANSPLANTATION PROCEEDINGS. 54(2), 242-247. doi:10.1016/j.transproceed.2022.01.006
  13. Gunarathne, Thalwaththe Gedara Nadeeka Shayamalie; Tang, Li Yoong; Lim, Soo Kun; Nanayakkara, Nishantha; Damayanthi, Hewaratne Dassanayakege Wimala Thushari; Abdullah, Khatijah L. (2022). Factors Associated with Symptom Burden in Adults with Chronic Kidney Disease Undergoing Hemodialysis: A Prospective Study, INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. 19(9). doi:10.3390/ijerph19095540
  14. Jalalonmuhali, Maisarah; Ng, Kok Peng; Lee, Yee Wan; Gan, Chye Chung; Hing, Albert (Wong); Adnan, Wan Ahmad Hafiz Wan Md; Cheng, Shian Feng; Chew, Chang Chuan; Ooi, Shok Hoon; Wong, Chew Ming; Lim, Soo Kun (2022). The Effects of Different Induction Regimes on Serial Lymphocyte Subsets in Kidney Transplant Recipients: A Single Tertiary Center Experience, TRANSPLANTATION PROCEEDINGS. 54(2), 299-306. doi:10.1016/j.transproceed.2022.01.004
  15. Lau, Wai Pooi; Ng, Kok Peng; Ganapathy, Shubash Shander; Tah, Pei Chein; Ismail, Rokiah; Jalalonmuhali, Maisarah; Lim, Soo Kun (2022).

    Prevalence Rate of Proteinuria and Metabolic Acidosis Among Kidney Transplant Recipients in a Tertiary Teaching Hospital and Its Relationship to Dietary Intake

    , TRANSPLANTATION PROCEEDINGS. 54(2), 355-361. doi:10.1016/j.transproceed.2021.12.019
  16. Lim, Soo Kun; Goh, Bak Leong; Visvanathan, Ravindran; Kim, Su Hyun; Jeon, Jin Seok; Kim, Sung Gyun; Chang, Jae Hyun; Lim, Chun Soo; Morad, Zaki (2022). A multicentre, multi-national, double-blind, randomised, active-controlled, parallel-group clinical study to assess the safety and efficacy of PDA10 (Epoetin-Alfa) vs. Eprex (R) in patients with anaemia of chronic renal failure (vol 22, 391, 2021), BMC NEPHROLOGY. 23(1). doi:10.1186/s12882-021-02651-0
  17. Paneerselvam, Ganesh Sritheran; Aftab, Raja Ahsan; Sirisinghe, Roland Gamini; Lai, Pauline Siew Mei; Lim, Soo Kun (2022). Study protocol: Effectiveness of patient centered pharmacist care in improving medication adherence, clinical parameters and quality of life among hemodialysis patients, PLOS ONE. 17(2). doi:10.1371/journal.pone.0263412
  18. Peng-Ng, Kok; Wei-Lim, Kai; Lau, Wai-Pooi; Thye, Chee-Keong; Hing, Albert; Cheng, Shian-Feng; Chew, Chang-Chuan; Lee, Yee-Wan; Ooi, Shok-Hoon; Maisarah, J.; Lim, Soo-Kun (2022).

    Utility of Estimated Glomerular Filtration Rate Equations in Assessing Renal Allograft Function: Are They Accurate?

    , TRANSPLANTATION PROCEEDINGS. 54(2), 329-334. doi:10.1016/j.transproceed.2022.01.012
  19. Teh, Yoong Mond; Mualif, Siti Aisyah; Lim, Soo Kun (2022). A comprehensive insight into autophagy and its potential signaling pathways as a therapeutic target in podocyte injury, INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. 143. doi:10.1016/j.biocel.2021.106153
  20. Thye, Chee Keong; Lee, Yee Wan; Jalalonmuhali, Maisarah; Lim, Soo Kun; Ng, Kok Peng (2022).

    The Utility of Combined Urine Urea and Creatinine Clearance for Pretransplant Renal Function Assessment

    , TRANSPLANTATION PROCEEDINGS. 54(2), 254-259. doi:10.1016/j.transproceed.2021.12.023
  21. Abbasi, S. H., Aftab, R. A., Lai, P. S. M., Lim, S. K., & Abidin, R. N. Z. (2021). Impact of Healthcare Associated Infections on Survival and Treatment Outcomes Among End Stage Renal Disease Patients on Renal Replacement Therapy. Frontiers in Pharmacology, 12, 11. doi: 10.3389/fphar.2021.707511
  22. Ali, A. A., Lim, S. K., Tang, L., Rashid, A. A., & Chew, B. H. (2021). The effectiveness of nurse-led self-management support program for people with chronic kidney disease stage 3-4 (CKD-NLSM): Study protocol for a randomized controlled trial. Science Progress, 104(2), 27. doi: 10.1177/00368504211026159
  23. Gan, C. C., Jalalonmuhali, M., Nordin, N. Z., Wahab, M. Z. A., Yahya, R., Ng, K. P., . . . Lim, S. K. (2021). ABO-Incompatible Living-Donor Kidney Transplantation in a Developing Country: A Multicenter Experience in Malaysia. Transplantation Proceedings, 53(3), 856-864. doi: 10.1016/j.transproceed.2020.10.038
  24. Lim, J. L., Ng, E. Y., Lim, S. Y., Tan, A. H., Abdul-Aziz, Z., Ibrahim, K. A., . . . Ahmad-Annuar, A. (2021). Association study of MCCC1/LAMP3 and DGKQ variants with Parkinson's disease in patients of Malay ancestry. Neurological Sciences, 42(10), 4203-4207. doi: 10.1007/s10072-021-05056-x
  25. Lim, S. K., Goh, B. L., Visvanathan, R., Kim, S. H., Jeon, J. S., Kim, S. G., . . . Morad, Z. (2021). A multicentre, multi-national, double-blind, randomised, active-controlled, parallel-group clinical study to assess the safety and efficacy of PDA10 (Epoetin-alpha) vs. Eprex (R) in patients with anaemia of chronic renal failure. Bmc Nephrology, 22(1), 10. doi: 10.1186/s12882-021-02601-w
  26. Mahendran, R., Lim, S. K., Ong, K. C., Chua, K. H., & Chai, H. C. (2021). Natural-derived compounds and their mechanisms in potential autosomal dominant polycystic kidney disease (ADPKD) treatment. Clinical and Experimental Nephrology, 25(11), 1163-1172. doi: 10.1007/s10157-021-02111-x
  27. Said, N., Lau, W. J., Ho, Y. C., Lim, S. K., Abidin, M. N. Z., & Ismail, A. F. (2021). A Review of Commercial Developments and Recent Laboratory Research of Dialyzers and Membranes for Hemodialysis Application. Membranes, 11(10). doi: 10.3390/membranes11100767
  28. Teh, Y. M., Lim, S. K., Jusoh, N., Osman, K., & Mualif, S. A. (2021). CD80 Insights as Therapeutic Target in the Current and Future Treatment Options of Frequent-Relapse Minimal Change Disease. Biomed Research International, 2021, 17. doi: 10.1155/2021/6671552
  29. Wong, X. Z., Amirah, A., Gan, C. C., Fatiha, S., Maznah, D., Yahya, R., . . . Lim, S. K. (2021). Hepatitis C virus core antigen as alternative diagnostic algorithm for active hepatitis C virus infection among haemodialysis population: Cost implications. Nephrology, 26(5), 463-470. doi: 10.1111/nep.13862
  30. Yap, D. Y. H., McMahon, L. P., Hao, C. M., Hu, N., Okada, H., Suzuki, Y., . . . Comm, A. H.-P. R. (2021). Recommendations by the Asian Pacific society of nephrology (APSN) on the appropriate use of HIF-PH inhibitors. Nephrology, 26(2), 105-118. doi: 10.1111/nep.13835
  31. van der van der Beek, A. B., Koomen, J. V., Dekkers, C. C. J., Barbour, S. J., Boulton, D. W., Gansevoort, R. T., . . . Heerspink, H. J. L. (2021). Evaluation of the Pharmacokinetics and Exposure-Response Relationship of Dapagliflozin in Patients without Diabetes and with Chronic Kidney Disease. Clinical Pharmacokinetics, 60(4), 517-525. doi: 10.1007/s40262-020-00956-1
  32. Cherney, D. Z. I., Dekkers, C. C. J., Barbour, S. J., Cattran, D., Gafor, A. H. A., Greasley, P. J., . . . Investigators, D. (2020). Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial. Lancet Diabetes & Endocrinology, 8(7), 582-593.
  33. Jalalonmuhali, M., Caroll, R., Deayton, S., Emery, T., Humphreys, I., Lim, S. J., . . . Coates, T. (2020). Prevalence of AT1R antibody (AT1R-Ab) among Malaysian multi-ethnic population. Human Immunology, 81(12), 679-684. doi: 10.1016/j.humimm.2020.07.005
  34. Jalalonmuhali, M., Ng, K. P., Ong, C. S., Lee, Y. W., Adnan, W., & Lim, S. K. (2020). Low Immunologic Risk Living Related Renal Transplant Using Very Low-Dose Antithymocyte Globulin as Induction Therapy: A Single Tertiary Hospital Experience. Transplantation Proceedings, 52(6), 1709-1714. doi: 10.1016/j.transproceed.2020.02.139
  35. Jalalonmuhali, M., Ng, K. P., Shariff, N. H. M., Lee, Y. W., Wong, A. H., Gan, C. C., & Lim, S. K. (2020). One-Year Outcomes of Living Related Kidney Transplant in Patients With Preformed HLA Donor-Specific Antibodies: A Single-Center Experience in Malaysia. Transplantation Proceedings, 52(6), 1718-1722. doi: 10.1016/j.transproceed.2020.02.140
  36. Liew, A., Bavanandan, S., Prasad, N., Wong, M. G., Chang, J. M., Eiam-Ong, S., . . . Tang, S. C. W. (2020). ASIAN PACIFIC SOCIETY OF NEPHROLOGY CLINICAL PRACTICE GUIDELINE ON DIABETIC KIDNEY DISEASE - EXECUTIVE SUMMARY. Nephrology, 25, 3-11. doi: 10.1111/nep.13763
  37. Liew, A., Bavanandan, S., Prasad, N., Wong, M. G., Chang, J. M., Eiam-Ong, S., . . . Tang, S. C. W. (2020). Asian Pacific Society of Nephrology Clinical Practice Guideline on Diabetic Kidney Disease - An Executive Summary. Nephrology, 25(11), 809-817. doi: 10.1111/nep.13804
  38. Liew, A., Bavanandan, S., Prasad, N., Wong, M. G., Chang, J. M., Eiam-ong, S., . . . Tang, S. C. W. (2020). ASIAN PACIFIC SOCIETY OF NEPHROLOGY CLINICAL PRACTICE GUIDELINE ON DIABETIC KIDNEY DISEASE. Nephrology, 25, 12-45. doi: 10.1111/nep.13785
  39. Rehman, I. U., Lai, P. S. M., Kun, L. S., Lee, L. H., Chan, K. G., Khan, T. M. (2020). Chronic Kidney Disease-Associated Pruritus and Quality of Life in Malaysian Patients Undergoing Hemodialysis. Therapeutic Apheresis and Dialysis, 24(1), 17-25. doi: 10.1111/1744-9987.12862
  40. Sualeheen, A., Khor, B. H., Balasubramanian, G. V., Sahathevan, S., Ali, M. S. M., Narayanan, S. S., . . . Pa, T. C. H. I. (2020). Habitual Dietary Patterns of Patients on Hemodialysis Indicate Nutritional Risk. Journal of Renal Nutrition, 30(4), 322-332. doi: 10.1053/j.jrn.2019.09.010
  41. Wong, X. Z., Gan, C. C., Mohamed, R., Yahya, R., Ganapathy, S., Tan, S. S., & Lim, S. K. (2020). Hepatitis C core antigen testing to diagnose active hepatitis C infection among haemodialysis patients. BMC Nephrology, 21(1), 6. doi: 10.1186/s12882-020-02154-4
  42. Yugavathy, N., Huri, H. Z., Kun, L. S., Gafor, A. H. B., Geot, W. M., Bavanandan, S., & Seng, W. H. (2020). Clinical and genetic markers of erythropoietin deficiency anemia in chronic kidney disease (predialysis) patients. Biomarkers in Medicine, 14(12), 1099-1108. doi: 10.2217/bmm-2020-0205
  43. Beng, T. S., Yun, L. A., Yi, L. X., Yan, L. H., Peng, N. K., Kun, L. S., . . . Loong, L. C. (2019). The experiences of suffering of end-stage renal failure patients in Malaysia: a thematic analysis. Annals of Palliative Medicine, 8(4), 401-410. doi:10.21037/apm.2019.03.04
  44. Goh, K. K. K., Lai, P. S. M., Lim, S. K. (2019). Cross cultural adaptation and validation of the Malay Kidney Disease Quality of Life (KDQOL-36). Bmc Nephrology, 20, 9. doi:10.1186/s12882-019-1397-8
  45. Gopalai, A. A., Lim, J. L., Li, H. H., Zhao, Y., Lim, T. T., Eow, G. B., . . . Annuar, A. A. (2019). LRRK2 N551K and R1398H variants are protective in Malays and Chinese in Malaysia: A case-control association study for Parkinsons disease. Molecular Genetics Genomic Medicine, 7(11), 6. doi:10.1002/mgg3.604
  46. Lavinya, A. A., Lee, C. S., Hashim, O. H., Azwa, I., Rajasuriar, R., Lim, S. K., Wong, Y. F. (2019). Proteomics analysis of blood plasma in HIV-infected patients with chronic kidney disease. Clinical Biochemistry, 73, 90-97. doi:10.1016/j.clinbiochem.2019.08.006
  47. Mac Guad, R., Ng, K. P., Lim, S. K., Hirayama, K., Eng, H. S., Adnan, W. (2019). Renal Transplant Outcomes in Spousal and Living-Related Donors in Malaysia. Annals Academy of Medicine Singapore, 48(12), 403-411.
  48. Rehman, I. U., Lai, P. S. M., Lim, S. K., Lee, L. H., Khan, T. M. (2019). Sleep disturbance among Malaysian patients with end-stage renal disease with pruritus. Bmc Nephrology, 20, 8. doi:10.1186/s12882-019-1294-1
  49. Soon, P. G. K., Lim, S. K., Rampal, S., Su, T. T. (2019). A qualitative examination of barriers and solutions to renal transplantation in Malaysia: Key-informants perspective. Plos One, 14(8), 20. doi:10.1371/journal.pone.0220411
  50. Chadban, S. J., Eris, J. M., Kanellis, J., Pilmore, H., Lee, P. C., Lim, S. K., Woodcock, C., Kurstjens, N., Russ, G., Grp, S. S. (2014). A randomized, controlled trial of everolimus-based dual immunosuppression versus standard of care in de novo kidney transplant recipients, Transplant International. 27(3), 302-311
  51. Chai, H. C., Chua, K. H., Lim, S. K., Phipps, M. E. (2014). Insight into Gene Polymorphisms Involved in Toll-Like Receptor/Interferon Signalling Pathways for Systemic Lupus Erythematosus in South East Asia, Journal of Immunology Research. (9), Article
  52. Tumin, Makmor; Rasiah, Rajah; Noh, Abdillah; Satar, NurulHuda Mohd; Chong, Chin-Sieng; Lim, Soo-Kun; Ng, Kok-Peng (2014). Living kidney donation: the importance of public education, CLINICAL TRANSPLANTATION. 28(4), 423-427. doi:10.1111/ctr.12334
  53. Lim, S. K., Bee, P. C., Keng, T. C., Chong, Y. B. (2013). Resolution of epoetin-induced pure red cell aplasia 2 years later, successful re-challenge with continuous erythropoiesis receptor stimulator, Clinical Nephrology. 80(3), 227-230
  54. Tumin, M., Noh, A., Chong, C. S., Lim, S. K., Abdullah, N., Ng, K. P. (2013). Non-organ donors attitudes toward incentives, Clinical Transplantation. 27(3), E316-E319
  55. Tumin, M., Noh, A., Chong, C. S., Satar, N. M., Lim, S. K., Abdullah, N., Ng, K. P. (2013). Strategies targeted at motivating unrelated living kidney donation, Annals of Transplantation. 18, 314-319
  56. Chong, Y. B., Tan, L. P., Robinson, S., Lim, S. K., Ng, K. P., Keng, T. C., Kamarulzaman, A. (2012). Penicilliosis in lupus patients presenting with unresolved fever: A report of 2 cases and literature review, Tropical Biomedicine. 29(2), 270-276
  57. Iqbal, A. H. M., Lim, S. K., Ng, K. P., Tan, L. P., Chong, Y. B., Keng, T. C. (2012). Pneumocystis jirovecii pneumonia 13 years post renal transplant following a recurrent cytomegalovirus infection, Transplant Infectious Disease. 14(4), E23-E26
  58. Keng, T. C., Ng, K. P., Tan, L. P., Chong, Y. B., Wong, C. M., Lim, S. K. (2012). Rothia dentocariosa Repeat and Relapsing Peritoneal Dialysis-Related Peritonitis: A Case Report and Literature Review, Renal Failure. 34(6), 804-806
  59. Wong, C. M., Ng, K. P., Keng, T. C., Lim, S. K., Tan, S. Y. (2011). Impact of Interventional Nephrology on Outcome and Penetration Rate of a CAPD Program, Peritoneal Dialysis International. 312(194-U175), Article
  60. Thye, Y. L., Lim, S. K., Wong, C. M., Keng, T. C., Chong, Y. B., Tan, S. Y. (2008). Grossly delayed graft function in a living related kidney transplant recipient: A case report, TRANSPLANTATION PROCEEDINGS. 40((7)), 2435-2436
ESCI
  1. Abbasi, Saad Hanif; Aftab, Raja Ahsan; Mei Lai, Pauline Siew; Lim, Soo Kun; Nur Zainol Abidin, Ruwaida (2022). Prevalence, Microbial Etiology and Risk Factors Associated With Healthcare Associated Infections Among End Stage Renal Disease Patients on Renal Replacement Therapy, JOURNAL OF PHARMACY PRACTICE. . doi:10.1177/08971900221094269
  2. Wong, Albert Hing; Wong, Wei-Kei; Looi, Lai-Meng; Ratnasingam, Jeyakantha; Lim, Soo-Kun (2022). Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis with Renal and Lung Involvement, CASE REPORTS IN NEPHROLOGY AND DIALYSIS. 12(2), 105-111. doi:10.1159/000525182
Scopus
  1. Lim S.K., Lee S.W.H. (2024). Cost-effectiveness analysis of dapagliflozin for people with chronic kidney disease in Malaysia, PLoS ONE. 19(3 March). doi:10.1371/journal.pone.0296067
  2. Ng K.T., Lim W.E., Teoh W.Y., Lim S.K., bin Fadzli A.N., Loh P.S. (2024). Effects of perioperative dexmedetomidine on delayed graft function following renal transplant: a systematic review and meta-analysis, Brazilian Journal of Anesthesiology (English Edition). 74(6). doi:10.1016/j.bjane.2024.844534
  3. Ooi S.H., Ng K.P., Sthaneshwar P., Lim S.K., Khor P.Y., Lim J.Y., Siow W.S., Lim K.W., Azlan M. (2024). A study of hospitalized COVID-19 patients with AKI in a setting of multiracial developing country, BMC Nephrology. 25(1). doi:10.1186/s12882-024-03498-x
  4. Ooi Y.-G., Sarvanandan T., Hee N.K.Y., Lim Q.-H., Paramasivam S.S., Ratnasingam J., Vethakkan S.R., Lim S.-K., Lim L.-L. (2024). Risk Prediction and Management of Chronic Kidney Disease in People Living with Type 2 Diabetes Mellitus, Diabetes and Metabolism Journal. 48(2), 196-207. doi:10.4093/dmj.2023.0244
  5. Paneerselvam G.S., Kenneth L.K.C., Aftab R.A., Sirisinghe R.G., Lai P.S.M., Lim S.K. (2024). Enhancing medication management in hemodialysis patients: Exploring the impact of patient-centered pharmacist care and motivational interviewing, PloS one. 19(5), e0300499. doi:10.1371/journal.pone.0300499
  6. Sharafaldin E.N.K., Sim M.S., Lim S.K., Alhussieni K., Huri H.Z. (2024). Precision medicine in lupus nephritis, Clinica Chimica Acta. 562. doi:10.1016/j.cca.2024.119894
  7. Wong Z.Y., Teo C.Y., Wong Y.Q.F., Ng K.T., Lim S.K. (2024). Immunosuppression for adult steroiddependent or frequently relapsing nephrotic syndrome: A systematic review and meta-analysis, PLoS ONE. 19(7 July). doi:10.1371/journal.pone.0307981
  8. Abbasi S.H., Aftab R.A., Mei Lai P.S., Lim S.K., Nur Zainol Abidin R. (2023). Prevalence, Microbial Etiology and Risk Factors Associated With Healthcare Associated Infections Among End Stage Renal Disease Patients on Renal Replacement Therapy, Journal of Pharmacy Practice. 36(5), 1142-1155. doi:10.1177/08971900221094269
  9. Kalantar-Zadeh K., Bellizzi V., Piccoli G.B., Shi Y., Lim S.K., Riaz S., Arronte R.U., Lau W.P., Fouque D. (2023). Caring for Patients With Advanced Chronic Kidney Disease: Dietary Options and Conservative Care Instead of Maintenance Dialysis, Journal of Renal Nutrition. 33(4), 508-519. doi:10.1053/j.jrn.2023.02.002
  10. Sharafaldin E.N.K., Huri H.Z., Sim M.S., Lim S.K. (2023). Potential immunological and genetic markers associated with lupus nephritis: From pathogenicity to therapeutic drug target, Autoimmunity Reviews. . doi:10.1016/j.autrev.2023.103406
  11. Soon P.G.K., Rampal S., Lim S.K., Su T.T. (2023). Effect of socioeconomic status and healthcare provider on post-transplantation care in Malaysia: A multi-centre survey of kidney transplant recipients, PLoS ONE. 18(4 April). doi:10.1371/journal.pone.0284607
  12. Thye C.K., Lee Y.W., Jalalonmuhali M., Lim S.K., Ng K.P. (2023). Creatinine clearance in selection of living kidney donor among the Malaysian population: is it safe?, BMC Nephrology. 24(1). doi:10.1186/s12882-023-03057-w
  13. Wong W.-K., Chan W.-K., Ganapathy S., Lim S.-K. (2023). Is metabolic-dysfunction-associated fatty liver disease or advanced liver fibrosis associated with erythropoietin stimulating agent hypo-responsiveness among patients with end-stage kidney disease on haemodialysis?, Nephrology. 28(8), 425-433. doi:10.1111/nep.14186
  14. Wong W.-K., Chan W.-K., Ganapathy S.S., Lim S.-K. (2023). Metabolic dysfunction-associated fatty liver disease (MAFLD) and advanced liver fibrosis among hemodialysis patients in a multiethnic urban population in Malaysia, Seminars in Dialysis. 36(2), 107-116. doi:10.1111/sdi.13117
  15. Yugavathy N., Abdullah B.M., Lim S.K., Abdul Gafor A.H.B., Wong M.G., Bavanandan S., Wong H.S., Huri H.Z. (2023). Precision Medicine in Erythropoietin Deficiency and Treatment Resistance: A Novel Approach to Management of Anaemia in Chronic Kidney Disease, Current issues in molecular biology. 45(8), 6550-6563. doi:10.3390/cimb45080413
  16. Thye, Y. L., Lim, S. K., Wong, C. M., Keng, T. C., Chong, Y. B., Tan, S. Y. (2008). Grossly Delayed Graft Function in a Living Related Kidney Transplant Recipient: A Case Report, Transplantation Proceedings. 40(7), 2435-2436
  17. Lim, S. K., Tan, S. Y. (2007). High dose Intravenous Immunoglobulin for Systemic lupus erythematosus with lupus nephritis and associated studies - case report, Journal of the University of Malaya Medical Centre. 10(2), 51-56
Others
  1. Desmond Y H Yap .... SK Lim, et al (2021). Recommendations by the Asian Pacific society of nephrology (APSN) on the appropriate use of HIF-PH inhibitors. Nephrology (Carlton). 2021 Feb;26(2):105-118.
  2. Maisarah J, .... SK Lim, et al (2020). Prevalence of AT1R antibody (AT1R-Ab) among Malaysian multi-ethnic population. Hum Immunol. Dec; 81(12):679-684.
  3. Megumi O, ..SK Lim, .. et al. (2020). Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice. Kidney Int. Dec 11;S0085-2538(20)31413-7.
  4. XZ Wong, CC Gan, R Mohamed, R Yahya, S Ganapathy, SS Tan, SK Lim (2020). Hepatitis C core antigen testing to diagnose active hepatitis C infection among haemodialysis patients. BMC Nephrol, Nov 13;21(1):480.
  5. Gan KS P, SK Lim, Rampal S, TT Su (2019). A qualitative examination of barriers and solutions to renal transplantation in Malaysia: Key-informants' perspective. PLoS One. 2019 Aug 12;14(8):e0220411.
  6. Gopalai, AA (2019). N551K and R1398H variants are protective in Malays and Chinese in Malaysia: A case-control association study for Parkinson's disease. Mol Genet Genomic Med. 2019 Nov;7(11):e604.
  7. MS Fu, SJ Lim, M Jalalonmuhali, KS Ng, SK Lim, KP Ng (2019). Clinical Significance of Renal Allograft Protocol Biopsies: A Single Tertiary Center Experience in Malaysia.
  8. Jalalonmuhali M, Elagel SMA, Tan MP, Lim SK, Ng KP. Estimating Renal Function in the Elderly Malaysian Patients Attending Medical Outpatient Clinic: A Comparison between Creatinine Based and Cystatin-C Based Equations. Int J Nephrol. 2018 May 13;2018:3081518.
  9. Maisarah Jalalonmuhali , Kok Peng Ng, Soo Jin Lim, Chun Seong Ong, Chew Ming Wong, Soo Kun Lim. Kidney transplant in sensitized patients: A case series from a premier teaching hospital in Malaysia. Transplantation Reports. Volume 3, Issue 1, March 2018, Pages 1-4.
  10. Jalalonmuhali M, Kok Peng N, Soo Kun L (2017). Comparative Performance of Creatinine-Based Estimated Glomerular Filtration Rate Equations in the Malays: A Pilot Study in Tertiary Hospital in Malaysia. Int J Nephrol. 2017;2017:2901581.
  11. Jalalonmuhali M, Lim SK, Md Shah MN, Ng KP. MDRD vs. CKD-EPI in comparison to 51-Chromium EDTA: a cross sectional study of Malaysian CKD cohort. BMC Nephrol. 2017 Dec 13;18(1):363.
  12. Rehman, I. U., Wu, D. B. C., Lai, P. S. M., Palanisamy, U. D., Lim, S. K. and Khan, T. M. (2017). "Translation of the 5D Itching Scale from English to Malay, and Its Validation among Patients with Chronic Kidney Disease in Malaysia." Frontiers in Medicine 4(189).
  13. Association of the receptor for advanced glycation end-products (RAGE) gene polymorphisms in Malaysian patients with chronic kidney disease. Wong FN, Chua KH, Kuppusamy UR, Wong CM, Lim SK, Tan JA. PeerJ. 2016 Apr 18;4:e1908. doi: 10.7717/peerj.1908.
  14. Clinical Impact of Education Provision on Determining Advance Care Planning Decisions among End Stage Renal Disease Patients Receiving Regular Hemodialysis in University Malaya Medical Centre. Hing Wong A, Chin LE, Ping TL, Peng NK, Kun LS. Indian J Palliat Care. 2016 Oct-Dec;22(4):437-445.
  15. Makmor T, NurulHuda MS, Raja Noriza RA, Soo-Kun L, Kok-Peng N, Wan Ahmad Hafiz WMA, Sook-Lu Y. 2016. Attendance And Institutional Facilities of Lonf-term Kidney Donors Follow-up. JUMMEC 19(1).
  16. Ng YM, Lim SK, Kang PS, Kadir KAA, Tai MLS. Association between serum 25-hydroxyvitamin D levels and carotid atherosclerosis in chronic kidney disease patients. BMC Nephrology
  17. Huri HZ, Lim LP, Lim SK. Glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with renal complications. Drug Des Devel Ther. 2015 Aug 7;9:4355-71.
  18. Identification and Characterization of a Rare Fungus, Quambalaria cyanescens, Isolated from the Peritoneal Fluid of a Patient after Nocturnal Intermittent Peritoneal Dialysis. Kuan CS, Yew SM, Toh YF, Chan CL, Lim SK, Lee KW, Na SL, Hoh CC, Yee WY, Ng KP. PLoS One. 2015 Dec 30;10(12):e0145932. doi: 10.1371/journal.pone.0145932.
  19. Tumin, M, et al. 2015. Determinants of willingness to become organ donors among dialysis patients' family members. Urology Journal 12(4): 2245-2250.
  20. Tumin, M., Mohd Satar, N.H., Raja Ariffin, R.N., et al. 2015. The importance of long-term follow-up visits for kidney donors. Journal of Health and Translational Medicine 18(2): 7-11.
  21. Tumin, M., Tafran, K., Zakaria, R.H., Mohd Satar, Mohd Satar, N., Ng, K.P., Lim, S.K. (2015). Do Family members of dialysis patients have a positive attitude toward organ donation? Ann Transplant, 20, 752-756. DOI: 10.12659/aot.894427
  22. Chadban SJ, Eris JM, Kanellis J, Pilmore H, Lee PC, Lim SK, Woodcock C, Kurstjens N, Russ G. A randomized, controlled trial of everolimus-based dual immunosuppression versus standard of care in de novo kidney transplant recipients. Transpl Int. 2014 Mar; 27(3):302-11.
  23. Gopalai AA, Lim SY, Chua JY, Tey S, Lim TT, Mohamed Ibrahim N, Tan AH, Eow GB, Abdul Aziz Z, Puvanarajah SD, Viswanathan S, Looi I, Lim SK, Tan LP, Chong YB, Tan CT, Zhao Y, Tan EK, Ahmad-Annuar A. LRRK2 G2385R and R1628P mutations are associated with an increased risk of Parkinson's disease in the Malaysian population.Biomed Res Int. 2014; 867321.
  24. Makmor Tumin, Muzalwana Abdul Talib Abdul Mutalib, NurulHuda Mohd Satar, Nawi Abdullah, Chin-Sieng Chong, Kok-Peng Ng, Soo-Kun Lim. 2014. A comparison of donor and control group quality of life. Annals of Transplantation 19(65):112-118
  25. Preliminary study of an exercise programme for reducing fatigue and improving sleep among long-term haemodialysis patients. Maniam R, Subramanian P, Singh SK, Lim SK, Chinna K, Rosli R. Singapore Med J. 2014 Sep;55(9):476-82.
  26. Radha Maniam, Pathmawathi Subramanian, Surindar Kaur Surat Singh, Soo Kun Lim, Karuthan Chinna, Roshaslina Rosli. 2014.Preliminary study of an exercise programme for reducing fatigue and improving sleep among long-term haemodialysis patients. Singapore Medical Journal. 55(9): 476-482
  27. Tumin, M. et al. 2014. Low organ donation rate in Malaysia: A survey. Journal of Health and Translational Medicine 17(1): 14-17.
  28. Tumin,M. et al. 2014. Organ donation campaigns: Perspective of dialysis patient's family members. Iranian Journal of Public Health 43(7): 926-935.
  29. Wan Md Adnan WAH, Zaharan NL, Wong MH, Lim SK (2014) The Effects of Intermittent Fasting during the Month of Ramadan in Chronic Haemodialysis Patients in a Tropical Climate Country. PLoS ONE 9(12): e114262. doi:10.1371/journal.pone.0114262
  30. Lim SK, Bee PC, Keng TC, Chong YB. Resolution of epoetin-induced pure red cell aplasia two years later, successful re-challenge with continuous erythropoiesis receptor stimulator. Clinical Nephrology 2012.
  31. Makmor Tumin, Abdillah Noh, Chong C.S., NurulHuda Mohd Satar, Lim S.K., Nawi Abdullah & Ng K.P. 2013. Strategies targeted at motivating unrelated living kidney donation. Annals of Transplantation 18: 314- 319.
  32. Tumin M, Noh A, Mohd Satar N, Chong C.S., Lim S.K., Abdullah N. & Ng K.P. 2013. Organ donation in Muslim countries: The case of Malaysia. Annals of Transplantation 18: 671-676.
  33. Tumin M., Noh A., Chong C.S., Lim S.K., Abdullah N. & Ng K.P. (2013). Non-organ donors' attitudes towards incentives. Clinical Transplantation. DOI:10.1111/ctr.12132
  34. Chong YB, Tan LP, Robinson S, Lim SK, Ng KP, Keng TC, Kamarulzaman A. Penicilliosis in lupus patients presenting with unresolved fever: A report of 2 cases and literature review. Tropical Biomedicine 29(2):270- 276 (2012)
  35. Keng TC, Ng KP, Tan LP, Chong YB, Wong CM, Lim SK. Rothia dentocariosa repeat and relapsing peritoneal dialysis-related peritonitis - a case report and literature review. Renal Failure 2012;34(6):804-6. Epub 2012 Apr 17 2012
  36. MH Wong, SK Lim, KL Ng, KP Ng. Pseudo-acute kidney injury with recurrent ascites due to intraperitoneal urine leakage: a case report. 2012. Internal Medicine Journal Jul;42(7):848-9
  37. Muhammad Iqbal AH, Lim SK, Ng KP, Tan LP, Chong YB, Keng TC. Pneumocystis jirovecii pneumonia 13 years post renal transplant following a recurrent cytomegalovirus infection. Transpl Infect Dis. 2012 May 3. doi:10.1111/j.1399-3062.2012.00738.x.
  38. Zhao Y, Gopalai A, Ahmad-Annuar A, Teng E, Prakash K, Tan L, Au WL, Li HH, Lim SY, Lim S, Chong Y, Tan L, Ibrahim N, Tan EK.Association of HLA locus variant in Parkinson's disease.Clin Genet. 2012 Oct 20. doi: 10.1111/cge.12024.
  39. Wong CM, Ng KP, Keng TC, Lim SK, Tan SY. Impact of interventional nephrology on outcome and penetration rate of CAPD program. Perit Dial Int.2011; 31(2): 194- 196.
  40. Thye YL, Lim SK, Wong CM, Keng TC, Chong YB, Tan SY. Grossly delayed graft function in a living related kidney transplant recipient: a case report. Transplant Proc. 2008 40(7):2435-6.
  41. SK Lim, SY Tan.2007.HIGH DOSE INTRAVENOUS IMMUNOGLOBULIN FOR SYSTEMIC LUPUS ERYTHEMATOSUS WITH LUPUS NEPHRITIS: REPORT OF 3 CASES AND REVIEW OF THE LITERATURE. JUMMEC 10(2): 51-56.
Books
  1. Jonathan Barratt, Peter Topham, Sue Carr, Mustafa Arici, Adrian Liew, .... Soo Kun Lim. (2021). Oxford Desk Reference Nephrology. Oxford University Press.
  2. Tumin, M & Mohd Satar N. 2015. Organ Shortage in Malaysia: The Public View. Kuala Lumpur: University of Malaya Press.
Other Publications
  1. Malaysian Dialysis Transplantation Registry 2011 - Technical Report
  2. Malaysian Registry of Renal Biopsy 2009 - Technical Report
  3. Malaysian Registry of Renal Biopsy 2008 - Technical Report
  4. Malaysian Registry of Renal Biopsy, 2007 - Technical Report

RESEARCH INTEREST

  • Expression of TGF-beta signalling on T-lymphocyte in Patients with Systemic Lupus Erythematosus (Systemic Lupus Erythematosus, TGF-beta, lupus nephritis)

RESEARCH PROJECT

National
  1. 2019 - 2023, Fundamental Research Grant Scheme (FRGS)
    Anti-proliferative Role Of 15,16-dihydrotanshinone I (dhts) Extracted From Salvia Miltiorrhiza In Autosomal Dominant Polycystic Kidney Disease (adpkd) Using In Vitro Model ( Co-Researcher)
  2. 2018 - 2021, Bantuan Kecil Penyelidikan (BKP)
    Outcome of Low Dose Thymoglobulin and Basiliximab as an Induction Therapy in Low Immunological Risk Living Related Renal Transplant in University Malaya Medical Center. ( Co-Researcher)
  3. 2016 - 2019, Fundamental Research Grant Scheme (FRGS)
    Association Of Clinical And Genetic Markers With Erythropoietin Deficiency Anemia And Erythropoietin Stimulating Agents Treatment Response In Pre-dialysis Chronic Kidney Disease ( Co-Researcher)
  4. 2017 - 2019, Geran Penyelidikan Universiti Malaya (UMRG Programme) - HTM (Wellness)
    Medication Adherence. Medication Burden, Drug Related Problems And Quality Of Life In Patients With End Stage Renal Disease ( Principal Investigator(PI))
  5. 2013 - 2018, Geran Penyelidikan Universiti Malaya (UMRG) - HTM (Wellness)
    Genetic Contributions To Adverse Drug Reactions (adr) In The Malaysian Population: Focus On Calcineurin Inhibitor Nephrotoxicity (cnit) ( Co-Researcher)
  6. 2015 - 2018, Bantuan Kecil Penyelidikan (BKP)
    Association of HLA gene polymorphism with risk of allosensitization in Malaysian dialysis patients ( Co-Researcher)
  7. 2015 - 2017, Bantuan Kecil Penyelidikan (BKP)
    Clinical Relevance of HLA Specific Antibodies in Renal Transplantation Patients ( Co-Researcher)
  8. 2015 - 2016, Postgraduate Research Grant (PPP) - Course & Disertation
    the long term outcome in biopsy-proven diabetic nephropathy and its clinical predictors ( Principal Investigator(PI))
  9. 2015 - 2016, Postgraduate Research Grant (PPP) - Course & Disertation
    Dietary Sodium Restriction in the Malaysian CKD population:Are we doing enough? ( Principal Investigator(PI))
  10. 2015 - 2016, Postgraduate Research Grant (PPP) - Course & Disertation
    Short term outcome of elderly End Stage Renal Failure starting on dialysis therapy ( Principal Investigator(PI))
  11. 2013 - 2015, Geran Penyelidikan Universiti Malaya (UMRG) - HTM (Wellness)
    Policy Study Of Organ Shortage: The Prospect Of Opt Out Model In Malaysia ( Co-Researcher)
  12. 2014 - 2015, Postgraduate Research Grant (PPP) - Course & Disertation
    Urinary Free Light Chain As A Potential Biomarker For Lupus Nephritis in UMMC ( Principal Investigator(PI))
  13. 2012 - 2013, Geran Penyelidikan Universiti Malaya (UMRG) - HTM (Wellness)
    CORRELATION OF PLAIN RADIOGRAPHS AND CORONARY ARTERY COMPUTED TOMOGRAPHY TO DETECT VASCULAR CALCIFICATION IN PRE DIALYSIS DIABETIC PATIENTS WITH CHRONIC KIDNEY DISEASE ( Co-Researcher)
  14. 2012 - 2013, Geran Penyelidikan Universiti Malaya (UMRG) - HTM (Wellness)
    Correlation Of Dual Energy X-ray Absorptiometry (bone Mineral Density And Abdominal Aorta Calcification) And Vascular Calcification In Coronary Artery Computed Tomography In Pre Dialysis Diabetic Chronic Kidney Disease Patients ( Co-Researcher)
  15. 2012 - 2013, Geran Penyelidikan Universiti Malaya (UMRG) - HTM (Wellness)
    Percutaneous Angioplasty Of Hemodialysis Fistulas: Factors Contributing To Early Restenosis Post Intervention ( Co-Researcher)
  16. 2019 - 2020, Private Funding
    A multice centre observational study to evaluate the clinical performance and safety of a new dialysis solution (SOFT FLOW SC) used in CAPD and automated peritoneal dialysis cycler (Lucenxia Intellis) system in patients with end stage kidney disease ( Principal Investigator(PI))
  17. 2014 - 2017, Private Funding
    A MULTI-CENTER, MULTI-NATIONAL, DOUBLE-BLIND, RANDOMIZED, ACTIVE-CONTROLLED, PARALLEL-GROUP CLINICAL STUDY TO ASSESS SAFETY AND EFFICACY OF PDA10 (EPOETIN-ALFA) COMPARED TO EPREX IN PATIENTS WITH ANEMIA OF CHRONIC RENAL FAILURE ( Principal Investigator(PI))
  18. 2012 - 2014, Exploratory Research Grant Scheme (ERGS)
    Organ Donation Awareness Campaigns Targeted at Families of Dialysis Patients ( Consultant)
  19. 2013 - 2014, Geran Penyelidikan Universiti Malaya (UMRG)
    Policy study of organ shortage: The prospect of opt- out model in Malaysia ( Consultant)
  20. 2012 - 2014, Geran Penyelidikan Universiti Malaya (UMRG)
    Correlation Of Dual Energy X-Ray Absorptiometry (Bone Mineral Density And Abdominal Aorta Calcification) And Vascular Calcification In Coronary Artery Computed Tomography In Pre Dialysis Diabetic Chronic Kidney Disease Patients ( Consultant)
  21. 2014 - 2014, NONE
    Assessment of glycaemic status in patients with Diabetes mellitus on haemodialysis using glycated albumin ( Principal Investigator(PI))
  22. 2011 - 2013, Geran Penyelidikan Universiti Malaya (UMRG)
    Expression of TGF-beta receptor and TGF-beta signaling on T lymphocytes in patients with systemic lupus erythematosus (SLE). ( Principal Investigator(PI))
  23. 2011 - 2012, Geran Penyelidikan Universiti Malaya (UMRG)
    Unseen incentives elements in altruistic model of organ donation. ( Consultant)
  24. 2010 - 2011, Geran Penyelidikan Universiti Malaya (UMRG)
    HOSPITAL UTILIZATION AMONG CHRONIC DIALYSIS PATIENTS ( Consultant)
  25. 2009 - 2010, Geran Penyelidikan Universiti Malaya (UMRG)
    Long Term Outcome Of Live Kidney Donation. Comparing Creatinine and Cystatin C-Based Methods To Estimate Residuel Renal Function ( Principal Investigator(PI))
  26. 2009 - 2010, Geran Penyelidikan Universiti Malaya (UMRG)
    Serum Level and Peritoneal Clearance of Beta-2 Microglobulinin Peritoneal Dialysis Patients. ( Consultant)
  27. 2007 - 2008, Short Term Research Fund (Vote F)(PJP)
    Cross-sectional study of BK virus infection in kidney transplant recipients. A single centre experience. ( Principal Investigator(PI))
Private
  1. 2020 - 2021, Private Funding
    Metabolica-associated Fatty Liver Disease (MAFLD) and Advanced Liver Fibrosis among Patients on Rental Replacement Therapy in Malaysia ( Principal Investigator(PI))
  2. 2019 - 2020, Private Funding
    Utilization Of Hcv Core Antigen In Hemodialysis Patients To Identify Patients Eligable For Hcv Treatment ( Principal Investigator(PI))
International
  1. 2019 - 2023, International Funding
    FLOW - Effect of semaglutide versus placebo on the progression of renal impairment in subjects with type 2 diabetes and chronic kidney disease (Protocol Trial ID: NN9535-4321) ( Principal Investigator(PI))
  2. 2016 - 2022, Private Funding
    Global Multicentre Kidney Transplant Advagraf Conversion Registry. A non-interventional post-authorisation study (PAS) ( Principal Investigator(PI))
  3. 2018 - 2022, Private Funding
    A multice ntre international randomized parallel group double-blind placebo-controlled clinical trial of EMPAgliflozin once daily to assess cardio-renal outcomes in patients with chronic KIDNEY disease (EMPA-KIDNEY STUDY) ( Principal Investigator(PI))
  4. 2016 - 2020, Private Funding
    AKB-6548-CI-0015: Phase 3, Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Maintenance Treatment of Anemia in Subjects with Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) (PRO2TECT - CONVERSION) ( Principal Investigator(PI))
  5. 2019 - 2020, International Funding
    A study of the natural history of leukocyte chemotactic factor 2 amyloidosis (ALECT2) disease ( Principal Investigator(PI))
  6. 2014 - 2019, Private Funding
    A Randomized, Double-blind, Event-driven, Placebo-controlled, Multicenter Study of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Subjects With Type 2 Diabetes Mellitus and Diabetic Nephropathy (CREDENCE) ( Principal Investigator(PI))
  7. 2017 - 2019, Private Funding
    A study to assess the Renoprotective Effects of the SGLT2 Inhibitor Dapagliflozin in Non- Diabetic Patients with Proteinuria: a Randomized Double Blind 6-Weeks Cross-Over Trial (DIAMOND) ( Principal Investigator(PI))
  8. 2010 - 2017, Private Funding
    A randomized, controlled, open-label, multi-centre, parallel-group study to assess all-cause mortality and cardiovascular morbidity in patients with chronic kidney disease on dialysis and those not on renal replacement therapy under treatment with MIRCERA or reference ESAs. (BH21260) ( Principal Investigator(PI))
  9. 2012 - 2017, Private Funding
    A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis Receiving Standard of Care Maintenance Therapy. (ATLAS) ( Principal Investigator(PI))
  10. 2010 - 2015, Private Funding
    A randomised, doubleblind, placebocontrolled, factorial design trial to assess the effect of aspirin and fish oil (omega3 fatty acids) in the prevention of early thrombosis in arteriovenous fistulae in patients with Stage IV or V chronic kidney disease requiring haemodialysis (FAVOURED Study) ( Principal Investigator(PI))
  11. 2006 - 2010, Private Funding
    Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis (ALMS) ( Principal Investigator(PI))

CONSULTANCY PROJECT

  • National Strategic Action Plan for Kidney Health (Act-Kid) 2026-2030, Ministry of Health, Consultant
    28 Jul 2023 - 28 Jul 2030 (National)
  • National Renal Registry Research and Publication Committee 2022 - 2024, National Renal Registry, Professional Consultant (Ir., Ar., Sr., Ts., dsbnya)
    06 Nov 2022 - 05 Nov 2024 (National)
  • National Renal Registry Advisory Committee, Malaysian Society of Nephrology, Professional Consultant (Ir., Ar., Sr., Ts., dsbnya)
    03 Oct 2022 - 02 Oct 2024 (National)
  • Ahli Jawatankuasa Rang Undang Undang Transplantasi Organ dan Tisu Manusia, Ministry of Health, Professional Consultant (Ir., Ar., Sr., Ts., dsbnya)
    01 May 2022 - 01 May 2024 (National)
  • National Transplant Technical Committee, Ministry of Health, Professional Consultant (Ir., Ar., Sr., Ts., dsbnya)
    18 Mar 2022 - 17 Mar 2024 (National)
  • Committee Member of Moh Jawatankuasa Kerja Ubat-Ubatan (Jkku), 2022-2024, Ministry of Health, Professional Consultant (Ir., Ar., Sr., Ts., dsbnya)
    23 Jan 2022 - 22 Jan 2024 (National)
  • 2022 Focused Update On Management of Atrial Fibrillation Writing Committee, National Heart Association , Professional Consultant (Ir., Ar., Sr., Ts., dsbnya)
    12 Mar 2022 - 11 Mar 2023 (National)
  • Round Table Discussion On End Stage Renal Disease, Boehringer Ingelheim International GmbH, Professional Consultant (Ir., Ar., Sr., Ts., dsbnya)
    13 Oct 2022 - 14 Oct 2022 (International)
  • Astrazeneca Hyperkalemia Advisory Board Meeting, AstraZeneca, Professional Consultant (Ir., Ar., Sr., Ts., dsbnya)
    16 Jul 2022 - 16 Jul 2022 (National)
  • Boehringer Ingelheim S Standalone Regional Kidney Steering Committee Meeting, Boehringer Ingelheim, Professional Consultant (Ir., Ar., Sr., Ts., dsbnya)
    25 Jun 2022 - 25 Jun 2022 (International)
  • Ckd Advisory Board Meeting, Boehringer Ingelheim (Malaysia) Sdn. Bhd., Professional Consultant (Ir., Ar., Sr., Ts., dsbnya)
    19 Jun 2022 - 19 Jun 2022 (National)
  • Medical Advisory Committee (Department Representative), University of Malaya
    01 May 2016 - 01 May 2022 (National)
  • Boehringer Ingelheim Regional Kidney Steering Committee Meeting, Boehringer Ingelheim , Professional Consultant (Ir., Ar., Sr., Ts., dsbnya)
    26 Mar 2022 - 26 Mar 2022 (International)
  • Novo Nordisk Oral Semaglutide Advisory Board, Novo Nordisk, Professional Consultant (Ir., Ar., Sr., Ts., dsbnya)
    12 Mar 2022 - 12 Mar 2022 (National)
  • Committee Member of Moh Jawatankuasa Kerja Ubat-Ubatan (Jkku), 2020-2022, MOH
    01 Jan 2020 - 01 Jan 2022 (National)
  • Ahli Jawatankuasa Kecil Penilaian Kepakaran Perubatan (Jkkpkp) - Nefrologi, MALAYSIA MEDICAL COUNCIL
    01 Dec 2019 - 01 Dec 2021 (National)
  • Visiting Consultant for UiTM Kidney Transplant Program, UiTM
    01 Feb 2017 - 01 Feb 2021 (National)
  • Cpg for Management of T2dm (5th Edition) Workgroup, Malaysia Endocrine & Metabolic Society(MEMS)
    01 Dec 2019 - 01 Dec 2020 (National)
  • Apsn Dm Nephropathy Clinical Practice Guidelines Workgroup, Asian Pacific Society of Nephrology
    01 Dec 2019 - 01 Dec 2020 (International)
  • Advisory Board for Dapa-Ckd Study, AstraZeneca
    01 May 2020 - 01 May 2020 (National)
  • External Reviewer of Moh Health Technology Assessment Report On Pre-Dialysis Education Program, MOH
    01 Jan 2020 - 01 Jan 2020 (National)
  • Advisory Board for Novo Nordisk Once Weekly Semaglutide, NovoNordisk
    01 Jan 2020 - 01 Jan 2020 (National)
  • Asian Pacific Society of Nephrology(Apsn) Hif-Ph Inhibitor Recommendation Committee, Asian Pacific Society of Nephrology
    01 Jan 2020 - 01 Jan 2020 (International)
  • Trulicity Expert Panel, 11 July 2020, ZUELIG PHARMA
    01 Jan 2020 - 01 Jan 2020 (National)
  • A Randomized, Double-Blind, Event-Driven, Placebo-Controlled, Multicenter Study of The Effects of Canagliflozin On Renal and Cardiovascular Outcomes in Subjects With Type 2 Diabetes Mellitus and Diabetic Nephropathy (Credence Study) - National Leader, JANSSEN
    01 Dec 2014 - 01 Dec 2019 (National)
  • Revise Nephrology, Renal Division, Department of Medicine
    01 May 2019 - 01 May 2019 (National)
  • 4th Clinical Practice Guidelines On The Management of Hypertension Expert Panel, MALAYSIAN SOCIETY OF HYPERTENSION
    01 Feb 2017 - 01 Feb 2019 (National)
  • Advisory Board for B Vitamins Injection and Peripheral Neuropathy, P & G Heath
    01 Feb 2019 - 01 Feb 2019 (National)
  • Asia Lupus Nephritis Advisory Board, Astellas
    01 Dec 2018 - 01 Dec 2018 (International)
  • Asia Pacific Advisory Board for Ckd-Mbd, Sanofi-Aventis
    01 Dec 2017 - 01 Dec 2017 (International)
  • Ketosteril Advisory Board Meeting, Fresenius Kabi
    01 Dec 2016 - 01 Dec 2016 (International)
  • Lucenxia Peritoneal Dialysis (Pd) Advisoty Board Member, Lucenxia
    01 Dec 2016 - 01 Dec 2016 (National)
  • Asia-Pacific Transplantation Expert Meeting, Astellas Pharma
    01 Dec 2016 - 01 Dec 2016 (International)
  • Malaysia Linagliptin Experts Advisory Panel, Boehringer Ingelheim
    01 Dec 2012 - 01 Dec 2015 (National)
  • Diabetes Advisory Board(Astra Zeneca), ASTRA ZENECA
    01 Dec 2013 - 01 Dec 2014 (National)
  • Urogenital Infection in Diabetes Expert Panel, ASTRA ZENECA
    01 Dec 2014 - 01 Dec 2014 (National)
  • Sanofi Asia Pacific Renal Advisory Board On Renal Bone Disease, Sanofi-aventis
    01 Dec 2011 - 01 Dec 2014 (National)

PAPER PRESENTED

INVITED SPEAKER
  1. Beta-Trace Protein (BTP) as A Potential Biomarker for Patients on Hemodialysis , Shaping Future Diagnostics with Siemens Healthineers , Siemens (National) (30 Nov 2023 - 30 Nov 2023)
  2. The New Evolution of CKD Treatment Involving Malaysian Patients, NPRA Lunch Talk, Boeringer Ingelheim (National) (30 Nov 2023 - 30 Nov 2023)
  3. Navigating Diabetes & Renal Impairment, UMSC CME GP Symposium, UM Specialist Centre (National) (26 Nov 2023 - 26 Nov 2023)
  4. Case Study It s all about Patient, Cardiovascular Metabolic (CVM) Congress, Boeringer Ingelheim (National) (04 Nov 2023 - 04 Nov 2023)
  5. Common Electrolyte/ Acid-Base Disorders in Onco-Nephrology , PGRSM Scietific Meeting Series 3/2023: Acid & Electrolytes, PGRSM (National) (04 Nov 2023 - 05 Nov 2023)
  6. Breakfast Chat: Updates in Current Management Across Cardio-Renal-Metabolic Continuum - What's new on the horizon and where are we going?, FOCUS+ Summit 2023, AstraZeneca (National) (29 Oct 2023 - 29 Oct 2023)
  7. Unmet Needs in Management of Kidney Failure and Future Directions, 7th Annual Congress of the Asia-Pacific Society for Artificial Organs (APSAO) , Asia-Pacific Society for Artificial Organs (APSAO) (International) (25 Sep 2023 - 26 Sep 2023)
  8. Stroke Prevention in AF: Fly Me To The Moon, MHRS.tv XA Factor Season 3 Episode 1, Menarini Malaysia (National) (23 Sep 2023 - 23 Sep 2023)
  9. Supplemented low protein diet in CKD - who will benefit the most , Ketoanalogues MasterClass 2023, Fresenius Kabi (National) (10 Sep 2023 - 10 Sep 2023)
  10. Rethink the Approach to Hyperkalemia in CKD, Ketoanalogues MasterClass 2023, Fresenius Kabi (National) (10 Sep 2023 - 10 Sep 2023)
  11. Multidisciplinary CKD Management, Ketoanalogues MasterClass 2023, Fresenius Kabi (National) (09 Sep 2023 - 10 Sep 2023)
  12. CKD risk stratification & implication on practice, Ketoanalogues MasterClass 2023, Fresenius Kabi (National) (09 Sep 2023 - 09 Sep 2023)
  13. Beta-Trace Protein (BTP) as a potential biomarker for patients on hemodialysis, 33 MACB Conference 2023, MACB (National) (04 Sep 2023 - 05 Sep 2023)
  14. CKD Education and Modality Options for Patients , 17th ANNUAL DIALYSIS CONFERENCE 2023, National Kidney Foundation (National) (05 Aug 2023 - 06 Aug 2023)
  15. Debate: Multiple versus Single Pill Combination (SPC) Antihypertensive Therapy: Loss and Gains, MSH 18th Annual Scientific Congress 2023, Malaysian Society of Hypertension (National) (14 Jul 2023 - 16 Jul 2023)
  16. What might the future hold for GLP-1Rs in T2DM patient with CKD, 37th Annual Congress of MSN, 7th July 2023, Malaysian Society of Nephrology (National) (07 Jul 2023 - 09 Jul 2023)
  17. Lupus Nephritis - New Insights into Pathogenesis and Treatment, 37th Annual Congress of MSN, 7th July 2023, Malaysian Society of Nephrology (National) (07 Jul 2023 - 09 Jul 2023)
  18. From Bench to Bedsides: Bringing Innovation to Diabetes Treatment in Renal Patients, 37th Annual Congress of MSN, 7th July 2023, Malaysian Society of Nephrology (National) (07 Jul 2023 - 09 Jul 2023)
  19. What is the evidence of SGLT2i in CKD?, SGH Lunch Webinar, Boeringer Ingelheim (International) (05 Jul 2023 - 05 Jul 2023)
  20. Revisit the Important Role of Keto Acids Therapy in Retarding CKD Progression, Keto Acids Roundable, Fresenius Kabi (National) (24 Jun 2023 - 24 Jun 2023)
  21. Latest Evidence on Management in Diabetic Kidney Disease(DKD), 8th Hospital Serdang Pharmacy Conference, Serdang Pharmacy Department (National) (10 Jun 2023 - 10 Jun 2023)
  22. HLA Incompatible Kidney Transplantation Strategies & Challenges, 26th Annual Scientific Meeting Malaysian Society of Transplantation, Malaysian Society of Transplantation (National) (26 May 2023 - 28 May 2023)
  23. Delaying CKD Progression: Reducing the Residual Risk, MSN CKD Masterclass 2023, Malaysian Society of Nephrology (National) (21 May 2023 - 21 May 2023)
  24. HYPERTENSION WITH CHRONIC KIDNEY DISEASE, WEBINAR, SANOFI (National) (17 May 2023 - 17 May 2023)
  25. Presentation title: Older Patients with Atrial Fibrillation: Are We Missing the Broader Picture?, TAC Summit, Bayer Malaysia (National) (13 May 2023 - 13 May 2023)
  26. IMPLEMENTING KETOANALOGUES THERAPY: BEST PRACTICE SHARING - Perspective from Malaysia, IKS Asia 2023, Fresenius Kabi (International) (06 May 2023 - 07 May 2023)
  27. Curable Kidney Disease: Diagnosis & Management, SinChew Public Talk, SinChew Press (National) (18 Mar 2023 - 18 Mar 2023)
  28. Case Discussion: T2D patient with low albuminuria diagnosed with CKD, Kidney Cornerstone Session 2 Hybrid Event, Boehringer Ingelheim Malaysia (National) (11 Mar 2023 - 11 Mar 2023)
  29. Tacrolimus in kidney transplantation Fun facts, POSTGRADUATE RENAL SOCIETY OF NEPHROLOGY (PGRSM) WORKSHOP, PGRSM (National) (04 Mar 2023 - 05 Mar 2023)
  30. The Nephro Story: Achieving Stability with the Kidney in Mind, PGA Voyage Scientific Summit, Novo Nordisk (National) (25 Feb 2023 - 25 Feb 2023)
  31. CKD: Diabetic & Hypertension - What a dialysis nurse should know ?, NKF Post-basic Renal Nursing Course, National Kidney Foundation (National) (03 Feb 2023 - 03 Feb 2023)
  32. Pregnancy & Kidney Disease, NKF Post-basic Renal Nursing Course, National Kidney Foundation (National) (31 Jan 2023 - 31 Jan 2023)
  33. Mineralocorticoids in CKD, PGRSM Scientific Meeting Series 3/2022, POST-GRADUATE RENAL SOCIETY OF MALAYSIA (National) (01 Oct 2022 - 02 Oct 2022)
  34. Low blood sugar: Killer for kidney disease patients?, UMMC Multi-Discipline Insulin Workshop Edition 1.0, UMMC ENDOCRINE UNIT (National) (10 Sep 2022 - 10 Sep 2022)
  35. Managing the patient with a failing kidney allograft, 2nd Singapore Transplant Nephrology & Urology Review Course, SINGAPORE GENERAL HOSPITAL (International) (27 Aug 2022 - 28 Aug 2022)
  36. Vitamin and mineral deficiency in chronic dialysis patients : Do we overlook ?, 19th ADMAN Annual Dialysis Conference., ADMAN SOCIETY (National) (06 Aug 2022 - 07 Aug 2022)
  37. Intradialytic hypertension, PGRSM Scientific Meeting Series 2/2022, POST-GRADUATE RENAL SOCIETY OF MALAYSIA (National) (30 Jul 2022 - 31 Jul 2022)
  38. Proteins & Kidneys: When to initiate low protein intake?, 7th Malaysian Dietitians Association Hybrid Conference, Malaysian Dietitians Association (National) (28 Jun 2022 - 28 Jun 2022)
  39. Delay progression of Chronic Kidney Disease - Everyone's Effort Counts, MDES Virtual Conference, MALAYSIAN DIABETIC EDUCATOR SOCIETY (National) (24 Jun 2022 - 24 Jun 2022)
  40. Recurrence of Disease after Kidney Transplantation - Special Considerations in Management, 25th Annual Scientific Meeting Malaysian Society of Transplantation, Malaysian Society of Transplantation (National) (27 May 2022 - 29 May 2022)
  41. Clinical perspectives: Calciphylaxis in Hyperphosphatemia, Philippine Society of Nephrology Lunch Symposium (Sanofi), Philippine Society of Nephrology (International) (27 Apr 2022 - 27 Apr 2022)
  42. Low Blood Sugar: Killer for kidney disease patients, WEBINAR, Novo Nordisk (National) (24 Apr 2022 - 24 Apr 2022)
  43. Membranous nephropathy: evolving pathogenesis and management, PGRSM Scientific Meeting Series 1/2022, POST-GRADUATE RENAL SOCIETY OF MALAYSIA (PGRSM) (National) (26 Mar 2022 - 27 Mar 2022)
  44. Protecting the Kidneys in Heart Failure - A Patient Case, HF SPACE Symposium , NOVARTIS (National) (19 Mar 2022 - 19 Mar 2022)
  45. Chronic Kidney Disease, Public Talk, SinChew Press (National) (13 Mar 2022 - 13 Mar 2022)
  46. Relationship Between Blood Pressure Control & Treatment Adherence Among Your Hypertensive Patients, World Congress of Nephrology Sponsored Symposium (Abbott), Malaysian Society of Nephrology (International) (27 Feb 2022 - 27 Feb 2022)
  47. Vascular Calcification in CKD The Hidden Threat, World Congress of Nephrology Lunch Symposium (Sanofi), Malaysian Society of Nephrology (International) (25 Feb 2022 - 25 Feb 2022)
  48. Treatment of Type II Diabetes with CKD, World Congress of Nephrology, Malaysian Society of Nephrology (International) (24 Feb 2022 - 27 Feb 2022)
  49. CKD and COVID-19 - Challenges and approaches to manage CKD and renal anemia during COVID-19 Pandemic, Impact of COVID-19 on kidney health Webinar, Roche (National) (18 Feb 2022 - 18 Feb 2022)
  50. CPG Management of T2DM - Diabetic Kidney Disease & Diet, Diabetic CPG Webinar, Malaysian Endocrine & Metabolic Society (National) (15 Jan 2022 - 15 Jan 2022)
  51. Overview of CKD-MBD, CKD-MBD Workshop What dialysis nurses need to know? , Renal Division, UMMC (National) (09 Jan 2022 - 09 Jan 2022)
  52. Heart Failure & Chronic Kidney Disease A Clinical Dilemma, Heralding The New Era of Heart Failure Treatment Webinar, Novartis (National) (08 Jan 2022 - 08 Jan 2022)
  53. Rehydrating Kidney Landscape, MYSG Cardiorenal Metabolic Summit, Boehringer Ingelheim (Malaysia) Sdn. Bhd. (International) (22 May 2021 - 22 May 2021)
  54. Pregnancy & The Kidneys, NKF Post-basic Renal Nursing, National Kidney Foundation (National) (11 May 2021 - 11 May 2021)
  55. Chronic Kidney Disease: DM & HPT, NKF Post-basic Renal Nursing Course , National Kidney Foundation (National) (10 May 2021 - 10 May 2021)
  56. ABG Simple as ABC, MMA Webinar, Society of Malaysian Medical Association Medical Students (SMMAMS) (National) (18 Apr 2021 - 18 Apr 2021)
  57. Practical considerations of initiation of RAASi/ ARNi in HF patients, renal safety and long term efficacy of ARNi, Heart Failure Live Webinar, Novartis Corporation (M) Sdn. Bhd. (National) (13 Mar 2021 - 13 Mar 2021)
  58. DIABETIC KIDNEY DISEASE, T2DM CPG 6TH EDITION LAUNCH 2021, MALAYSIAN ENDOCRINE & METABOLIC SOCIETY (National) (30 Jan 2021 - 30 Jan 2021)
  59. Comprehensive T2D Management: Going Beyond Glycaemic Control, BI Webinar, Boehringer Ingelheim (Malaysia) Sdn. Bhd. (National) (23 Jan 2021 - 23 Jan 2021)
  60. Comprehensive T2DM Management: Going Beyond Glycaemic Control, BI CME, Boehringer Ingelheim PHARMACEUTICAL (National) (23 Jan 2021 - 23 Jan 2021)
  61. Initiating the END-Organ Protection, but NEVER at the END, FOCUS + 2020 WEBINAR SERIES - RETHINKING DIABETIC KIDNEY DISEASE, ASTRA ZENECA (National) (12 Dec 2020 - 12 Dec 2020)
  62. Translating Theory to Therapy with Nephrologist and Dietitian Collaboration, VIRTUAL TALK, Hong Kong Society of Nephrology (International) (10 Dec 2020 - 10 Dec 2020)
  63. A Practical Guide for the Pharmacological Management of T2DM Patients across the Cardiovascular Risk Continuum , FOCUS+ 2020 Summit: Spotlight on Cardio-Renal-Metabolic Continuum, ASTRA ZENECA (National) (21 Nov 2020 - 22 Nov 2020)
  64. Heart Failure & Chronic Kidney Disease , DOCQUITY LECTURE, DOCQUITY (National) (03 Nov 2020 - 03 Nov 2020)
  65. Microvascular Complications in T2D Patients: Translating Clinical Data to Clinical Practice , Malaysia-Singapore On Air Forum Webinar, Boehringer Ingelheim Pharmaceutical  (International) (10 Oct 2020 - 10 Oct 2020)
  66. Metabolic Syndrome Post-Transplantation: Epidemiology, Prevention and Management, 23rd Annual Scientific Meeting of Malaysian Society of Transplantation , Malaysian Society of Transplantation (National) (18 Sep 2020 - 20 Sep 2020)
  67. A New Avenue to Protect the Kidneys, WEBINAR - PRIMARY CARE SEMINAR, Taisho Pharmaceutical (M) Sdn Bhd (National) (18 Jul 2020 - 18 Jul 2020)
  68. Deep Dive into REWIND and AWARD 7 Studies: Renal Outcomes, Trulicity Expert Panel Meeting , Zuellig Pharma Sdn Bhd (National) (11 Jul 2020 - 11 Jul 2020)
  69. Low Blood Sugar: Killer for Kidney Disease Patients?, Cross-talk: Today & Tomorrow , Novo Nordisk (National) (29 Feb 2020 - 29 Feb 2020)
  70. Multidisciplinary Management of CKD , UMMC International Nursing & Healthcare Congress, UMMC (International) (19 Feb 2020 - 21 Feb 2020)
  71. Ups & Downs: Challenges in Managing Labile BP Among Hemodialysis Patients, Malaysian Society Hypertension 17th Annual Congress , Malaysian Society Hypertension (National) (14 Feb 2020 - 16 Feb 2020)
  72. Metabolic acidosis: challenging issue for clinicians, POSTGRADUATE RENAL SOCIETY OF MALAYSIA (PGRSM) COURSE 2019 , POSTGRADUATE RENAL SOCIETY OF MALAYSIA (PGRSM)  (National) (15 Nov 2019 - 16 Nov 2019)
  73. Supplemented low protein diet in CKD who will benefit the most , Ketoanalogue MasterClass: CKD Camp , Fresenius-Kabi (National) (10 Nov 2019 - 10 Nov 2019)
  74. Multi-disciplinary management of CKD- Practical session, Ketoanalogue MasterClass: CKD Camp, Fresenius-Kabi (National) (10 Nov 2019 - 10 Nov 2019)
  75. Prioritising dietary intervention - Diabetic CKD (per-dialysis) with proteinuria, Ketoanalogue MasterClass: Renal Nutrition Workshop , Fresenius Kabi (National) (09 Nov 2019 - 09 Nov 2019)
  76. Principles of Plasma Exchange, Applications and Practical Issues - Rationale and Technique of Plasma Exchange and Its Applications, Case Based Discussions., 3RD ASIA PACIFIC AKI-CRRT 2019, MALAYSIAN SOCIETY OF NEPHROLOGY (International) (11 Oct 2019 - 14 Oct 2019)
  77. Pathophysiology of Diabetic Nephropathy and Its Impact to Patients, 18th ADMAN ANNUAL DIALYSIS CONFERENCE , Association of Dialysis Medical Assistants and Nurses Malaysia (National) (21 Sep 2019 - 22 Sep 2019)
  78. Mycophenolate Mofetil In The Management Of Lupus Nephritis , Lupus Asia Summit 2019, ROCHE PHARMACEUTICAL COMPANY (International) (17 Aug 2019 - 18 Aug 2019)
  79. Renal benefits of Qtern (DELIGHT), MEMS ANNUAL CONGRESS 2019 (MAC 10) , AZ LUNCH SYMPOSIUM (National) (19 Jul 2019 - 21 Jul 2019)
  80. Bone Disease & CKD, MEMS ANNUAL CONGRESS 2019 (MAC 10) , MALAYSIAN ENDOCRINE & METABOLIC SOCIETY (National) (19 Jul 2019 - 21 Jul 2019)
  81. Proven Diet Therapy in CKD Retardation, 35th Annual Congress of the Malaysian Society of Nephrology , MALAYSIAN SOCIETY OF NEPHROLOGY (National) (12 Jul 2019 - 14 Jul 2019)
  82. Role of Dialysis Paramedics in Reducing Dialysis Access Infection, 4TH CONGRESS OF ASIAN PACIFIC SOCIETY OF DIALYSIS ACCESS 2019 , MALAYSIA SOCIETY OF NEPHROLOGY (International) (11 Jul 2019 - 14 Jul 2019)
  83. Perioperative Care of Patients with Renal Impairment, Perioperative Care of Orthopaedic Patients Workshop , Dept.of Orthopaedic Surgery, UM (University) (02 Jul 2019 - 02 Jul 2019)
  84. Updates in Chronic Kidney Disease Management, College of Physicians Regional Conference 2019, DEPARTMENT OF MEDICINE, UNIVERSITY OF MALAYA (University) (21 Jun 2019 - 22 Jun 2019)
  85. CKD Retardation: What is new?, Post Graduate Renal Society Malaysia(PGRSM) COURSE 2019, Post Graduate Renal Society Malaysia (PGRSM) (National) (14 Jun 2019 - 15 Jun 2019)
  86. CKD Definition & Staging: Anything New?, Post Graduate Renal Society Malaysia(PGRSM) COURSE 2019 (Course), Post Graduate Renal Society Malaysia(PGRSM) (National) (14 Jun 2019 - 15 Jun 2019)
  87. Invigorating live organ donationprogram in Malaysia: What are thepriorities?, Malaysian Society of Transplantation Annual Scientific Meeting , Malaysian Society of Transplantation  (National) (25 Apr 2019 - 27 Apr 2019)
  88. Clues to Tubulointerstitial Disease in Diabetic Nephropathy, 11th Diabetes Complications Conference & Grand Rounds , NATIONAL DIABETES INSTITUTE (National) (19 Apr 2019 - 21 Apr 2019)
  89. How to get it right in eating for diabetic CKD?, 11th Diabetes Complications Conference & Grand Rounds, FRESENIUS KABI LUNCH SYMPOSIUM (Industry/company) (19 Apr 2019 - 21 Apr 2019)
  90. Preventing Progression of Diabetes Kidney Disease, Malaysian Diabetes Educators Society Conference , Malaysian Diabetes Educators Society (National) (29 Mar 2019 - 30 Mar 2019)
  91. Type of dialysis: Conventional, high flux, hemodiafiltration What, When and How?, POSTGRADUATE RENAL SOCIETY OF MALAYSIA (PGRSM) COURSE 2019, POSTGRADUATE RENAL SOCIETY OF MALAYSIA (PGRSM) (National) (22 Feb 2019 - 23 Feb 2019)
  92. "ARB or ACE- Inhibitors - Which is better for my patients?", MALAYSIAN SOCIETY OF HYPERTENSION 17th Annual Scientific Meeting , MALAYSIAN SOCIETY OF HYPERTENSION (National) (18 Jan 2019 - 20 Jan 2019)
  93. Clinical Experience: Keto-acids therapy in kidney disease Who will benefit the most ?, Ketoanalogue MasterClass, Fresenius Kabi Malaysia (National) (27 Nov 2016 - 27 Nov 2016)
  94. Updates on Renal Anemia, 13th NKF ANNUAL DIALYSIS MEETING 2016, National Kidney Foundation (National) (12 Nov 2016 - 13 Nov 2016)
  95. Importance of reviewing Urinary Casts, Sysmex Scientific Event (Urinalysis) Every Drop Counts in Urinalysis, Sysmec Corporation (National) (25 Oct 2016 - 25 Oct 2016)
  96. Renal protection in Diabetes Mellitus, Managing DM Workshop Inside Out, UMMC Endocrinology (National) (09 Oct 2016 - 09 Oct 2016)
  97. SGLT-2 Inhibitors in the Treatment of DM- Slowing down renal progression Is it possible?, Diabetes Asia, National Diabetes Society (National) (08 Oct 2016 - 08 Oct 2016)
  98. Improving Clinical Outcome Through Managing Phosphate Effectively, Annual Scientific Meeting & Workshop Pernefri 2016 Dinner Symposium, Indonesian Society of Nephrology (International) (07 Oct 2016 - 09 Oct 2016)
  99. CKD with concomitant Heart Disease: Benefits of Antiplatelet & Anticoagulation, POST GRADUATE COURSE IN NEPHROLOGY 2016, Post-graduate Renal Society of Malaysia (National) (02 Sep 2016 - 03 Sep 2016)
  100. SGLT-2 Inhibitors: The effects on kidneys, SGH Endocrinology Update, Singapore GH Endocrinology Department (International) (27 Aug 2016 - 27 Aug 2016)
  101. Keto-Acid therapy in CKD management-Myths & Facts, 6th ANNUAL SCIENTIFIC MEETING / REGIONAL MEDICAL UPDATES 2016, Malaysian Medical Association, Pahang (National) (13 Aug 2016 - 14 Aug 2016)
  102. Management of anemia in pre-dialysis CKD and dialysis, 50th Dialysis Educational Workshop, Roche Pharmaceutical Malaysia (National) (12 Aug 2016 - 13 Aug 2016)
  103. Infection Control in Dialysis Unit & Prevention in UTI, 17th APSIC Basic Training Course in Infection Control, Asia-Pacific Society of Infection Control (International) (01 Aug 2016 - 12 Aug 2016)
  104. Current Perspective in Hyperuricemia, Gout & the Kidney, UPDATE IN CHRONIC KIDNEY DISEASE WORKSHOP, Nephrology Department, Seremban (National) (30 Jul 2016 - 31 Jul 2016)
  105. CKD with concomitant Heart Disease: Benefits of Antiplatelet & Anticoagulation, UPDATE IN CHRONIC KIDNEY DISEASE WORKSHOP, Nephrology Department, Seramban (National) (30 Jul 2016 - 31 Jul 2016)
  106. EMPA-REG Outcome: The game changer in your T2D Management, 7th NATIONAL DIABETES CONFERENCE, National Diabetes Society (National) (29 Jul 2016 - 31 Jul 2016)
  107. Antibody-mediated rejection: Diagnosis & Management, 19th Annual Scientific Meeting of The Malaysian Society of Transplantation, Malaysian Society of Transplantation (National) (27 May 2016 - 28 May 2016)
  108. Update on CMV treatment and prevention, 19th Annual Scientific Meeting of The Malaysian Society of Transplantation, Malaysian Society of Transplantation (National) (27 May 2016 - 28 May 2016)
  109. Keto-acids therapy in chronic kidney disease management, Private Medical Practitioners Association of Selangor and KL(PMPASKL) Annual Conference 2016, PMPASKL (National) (23 Apr 2016 - 24 Apr 2016)
  110. Ketoanalogue therapy in kidney diseases - Malaysia perspective, 11th International Ketoanalogue Symposium, Fresenius Kabi Global (International) (08 Apr 2016 - 09 Apr 2016)
  111. Tailoring hypertensive drugs and the kidney - A Case-based approach, 13th Annual Scientific Meeting, Malaysian Society of Hypertension, Malaysian Society of Hypertension (National) (15 Jan 2016 - 17 Jan 2016)
  112. Infection Control in Dialysis Unit & Prevention in UTI , 14th APSIC Basic Training Course in Infection Control, Asia-Pacific Society of Infection Control (International) (03 Nov 2014 - 03 Nov 2014)
  113. Initiation of PD therapy - When is the right time?, Post-Graduate Course in Nephrology:Update in Peritneal Dialysis. Petaling Jaya. 31 October 2014, PGRSM (National) (31 Oct 2014 - 31 Oct 2014)
  114. Achieving Optimal Dialysis Dose - Accurate Dialysis Measurement, PERNEFRI Conference, Annual Meeting & Workshop 2014, Indonesia Society of Nephrology (International) (18 Oct 2014 - 18 Oct 2014)
  115. Buttonhole technique - Should it be the method of choice?, KLVAC Pre-Congress Workshop, KLVAC 2014 (National) (16 Oct 2014 - 16 Oct 2014)
  116. Unmet needs in management of diabetic nephropathy, Malaysia Interchange in Diabetes, Eli Lily Pharmaceutical Company (National) (27 Sep 2014 - 27 Sep 2014)
  117. Use of RAS blockers and Proteinuria Management in CKD-What is the current thought?, MIMS CKD Workshop, MIMS (National) (07 Sep 2014 - 07 Sep 2014)
  118. Renal Transplantation Is it relevant to dialysis nurses?, SSL Dialysis Workshop, SSL HD Centre (National) (24 Aug 2014 - 24 Aug 2014)
  119. Overview of CKD Management, 2nd Renal Nutrition Seminar, National Kidney Foundation (National) (18 Aug 2014 - 18 Aug 2014)
  120. Adult Polycystic Kidney Disease - Anything New?, Seremban Hospital Nephrology Update, Nephrology Department Seremban Hospital (National) (14 Aug 2014 - 14 Aug 2014)
  121. Kidney disease & Pregnancy, Seremban Hospital Nephrology Update, Nephrology Department Seremban Hospital (National) (14 Aug 2014 - 14 Aug 2014)
  122. When Diabetes mellitus meets kidney disease ., Seremban Hospital Nephrology Update, Nephrology Department Seremban Hospital (National) (14 Aug 2014 - 14 Aug 2014)
  123. CKD Screening - Who What Why When, 1st Global Manipal Alumni Health Science & Technology Convention 2014, Manipal Alumni Malaysia (International) (07 Aug 2014 - 07 Aug 2014)
  124. Systemic Lupus Erythematosus (SLE) and Pregnancy, SYMPOSIUM ON OBSTETRICS & GYNAECOLOGY, UMMC O & G Department (University) (22 Jun 2014 - 22 Jun 2014)
  125. Debate: Dialysis is better than transplant Opposer, 17th Scientific Meeting of the Malaysian Society of Transplantation, MALAYSIAN SOCIETY OF TRANSPLANTATION (National) (24 May 2014 - 24 May 2014)
  126. The role of single-pill combination for the management of HPT in DM, NADI 2014, NADI (National) (10 May 2014 - 10 May 2014)
  127. Debate: Keto-acids supplement in addition to low protein diet is beneficial to CKD patients Opposer., MIMS CKD Workshop, MIMS (National) (27 Apr 2014 - 27 Apr 2014)
  128. Use of RAS blockers and Proteinuria Management in CKD-What is the current thought?, MIMS CKD Workshop, MIMS (National) (27 Apr 2014 - 27 Apr 2014)
  129. Infection Control in Dialysis Unit & Prevention in UTI , 13rd APSIC Basic Training Course in Infection Control, Infection Control Team (University) (23 Apr 2014 - 23 Apr 2014)
  130. Myths & Facts About Chronic Kidney Disease, Sau Seng Lum World Kidney Day Public Forum, Sau Seng Lum (National) (16 Mar 2014 - 16 Mar 2014)
  131. Fistula First Policy for the elderly , Diagnostic & Interventional in Nephrology (DIN), Malaysian Society of Nephrology (National) (21 Nov 2013 - 21 Nov 2013)
  132. Treatment of Hypertension in Patients with Renal Disease. , Resistant Hypertension in 2013: The Growing Health Challenge and the Role of Renal Denervation, Metronic, in collaboration with Malaysian Society of Hyeprtension (National) (09 Nov 2013 - 09 Nov 2013)
  133. Asia-Pacific experience in PD therapy. , International Society of Peritoneal Dialysis-Asian Pacific Chapter(ISPD-APCM), International Society of Peritoneal Dialysis (International) (29 Sep 2013 - 29 Sep 2013)
  134. Types of Dialysis: Conventional, High Flux, Haemodiafiltration: What, when and how. , Post-Graduate Course in Nephrology:Update in Haemodialysis, Post-Graduate Renal Society of Malaysia (National) (20 Sep 2013 - 20 Sep 2013)
  135. Infection Control in Dialysis Unit & Prevention in UTI , 12th APSIC Basic Training Course in Infection Control, Asia-Pacific Society of Infection Control (International) (12 Sep 2013 - 12 Sep 2013)
  136. Managing Diabetic Hemodialysis Patients , Sau Seng Lum Hemodialysis Workshop, Sau Seng Lum Hemodialysis Centre (National) (25 Aug 2013 - 25 Aug 2013)
  137. Kidney Disease in Type 2 Diabetes Mellitus., Asia-Pacific Diabetes Education Empowerment (ADEPT) Meeting, Astra-Zeneca (National) (21 Jul 2013 - 21 Jul 2013)
  138. CKD prevention & treatment. , Tzu-Chi Public Talk, Tzu-Chi Buddhist Organization (National) (20 Jul 2013 - 20 Jul 2013)
  139. Pre-dialysis CKD Education: What patients need to know?, 29th Annual Congress of Malaysian Society of Nephrology, Malaysian Society of Nephrology (National) (22 Jun 2013 - 22 Jun 2013)
  140. Diabetic Nephropathy, 4th National Diabetic Association Annual Conference (National) (15 Jun 2013 - 15 Jun 2013)
  141. Approach to Increased in Serum Creatinine, UMSC General Practitioner Symposium, UM Specialist Centre (National) (12 May 2013 - 12 May 2013)
  142. Chronic Kidney Disease & Proteinuria, Malaysian Diabetes Educators Society Seminar, Malaysian Diabetes Educators Society  (National) (27 Apr 2013 - 27 Apr 2013)
  143. Preparing for parathyroidectomy in HD patients, UMMC Haemodialysis Workshop, UMMC (National) (14 Apr 2013 - 14 Apr 2013)
  144. Diabetic Nephropathy, Diabetic Educator Post-basic Course, National Diabetic Institude (National) (02 Apr 2013 - 02 Apr 2013)
  145. Infection Control in Dialysis Unit & Prevention in UTI , 11th APSIC Basic Training Course in Infection Control, Asian Pacific Society of Infection Control (International) (19 Mar 2013 - 19 Mar 2013)
  146. Red Blood Cells & You, ADOPT Program, Malaysian Society of Nephrology (National) (24 Feb 2013 - 24 Feb 2013)
  147. Managing hypertension in Diabetes Mellitus, Primary Care Workshop, University Malaya Medical Centre Endocrine Unit (National) (12 Jan 2013 - 12 Jan 2013)
  148. Common Medications Used in SLE Treatment, Public forum, Malaysian SLE Society  (Others) (04 Nov 2012 - 04 Nov 2012)
  149. Kidney Involvement in SLE, Public forum, Malaysia SLE society (Others) (04 Nov 2012 - 04 Nov 2012)
  150. What can be done to induce an early fistula creation, 2nd Kuala Lumpur Vascular Access Conference(KLVAC), Vascular Society of Malaysia (Others) (04 Oct 2012 - 06 Oct 2012)
  151. Renoprotection in hypertension, Family Physician Specialist (FMS) close meeting, Sanofi Aventis Malaysia (National) (31 Aug 2012 - 31 Aug 2012)
  152. CKD prevention & treatment, Public talk, Tzu-Chi Organization (Others) (18 Aug 2012 - 18 Aug 2012)
  153. Common kidney conditions during pregnancy, O&G SYMPOSIUM, Malaysian O&G Society (National) (07 Jul 2012 - 08 Jul 2012)
  154. Kidney Disease & Pregnancy, O&G SYMPOSIUM, Malaysian O&G society (National) (07 Jul 2012 - 08 Jul 2012)
  155. What physicians need to know about CKD, Cardiometabolite Scientific Initiative, National Heart Institude (IJN) (National) (30 Jun 2012 - 30 Jun 2012)
  156. Diabetes mellitus & hypertension, Public talk, Tzu-Chi Organization (Others) (23 Jun 2012 - 23 Jun 2012)
  157. Diabetes mellitus & renal failure, National Diabetic Association Annual Conference, Malaysian Diabetic Association (National) (22 Jun 2012 - 23 Jun 2012)
  158. Cytomegalovirus in Renal Transplantation: Diagnosis & Management, Post Graduate Course in Nephrology, Post-Graduate Renal Society of Nephrology (PGRSM) (National) (15 Jun 2012 - 17 Jun 2012)
  159. CKD prevention & treatment, Public forum, Tzu-Chi Organization (Others) (28 Apr 2012 - 28 Apr 2012)
  160. Infection Control in Dialysis Unit & Prevention in UTI , 10th APSIC Basic Training Course in Infection Control, Malaysian Infection Control Society (Others) (16 Apr 2012 - 27 Apr 2012)
  161. Organ donation & cadaveric transplantation (In Mandarin), Public talk, Tzu Chi Organization (Others) (10 Mar 2012 - 10 Mar 2012)
  162. Principles of Continuous Renal Replacement Therapy (CRRT), CRRT Workshop (University) (06 Dec 2011 - 06 Dec 2011)
  163. CKD Progression: Role of Anaemia, Post Graduate Course in Nephrology: Update in Chronic Kidney Disease (National) (15 Oct 2011 - 15 Oct 2011)
  164. Kidney Disease & Pregnancy, Obstetric & Gynaecology Symposium (National) (09 Oct 2011 - 09 Oct 2011)
  165. Diagnosing Early Stage of Chronic Kidney Disease, Renal Anaemia in Pre-Dialysis Workshop  (National) (08 Oct 2011 - 08 Oct 2011)
  166. Treating anaemia early: The long term impact on health resources., Pharmacists Workshop on Renal Anaemia.  (National) (07 Oct 2011 - 07 Oct 2011)
  167. Renal Transplantation Overview , Critical Care Nursing Course (University) (07 Sep 2011 - 07 Sep 2011)
  168. Overview of kidney transplantation, Kidney Transplantation Workshop, Janssen-Cilag Sdn.Bhd. (National) (13 Aug 2011 - 13 Aug 2011)
  169. Immunosuppressive Regime - Rationale and New Trends , Kidney Transplantation Workshop, Janssen-Cilag (National) (13 Aug 2011 - 13 Aug 2011)
  170. Transplant Immunology, Kidney Transplantation Workshop, Janssen-Cilag (National) (13 Aug 2011 - 13 Aug 2011)
  171. Staging of CKD, CKD Workshop, UBM Medica Malaysia  (National) (18 Jun 2011 - 19 Jun 2011)
  172. Differentiating acute renal failure from chronic kidney disease, CKD Workshop, UBM Medical Malaysia (National) (18 Jun 2011 - 19 Jun 2011)
  173. Renal Anaemia, Renal Nutrition Seminar, National Kidney Foundation (National) (11 Jun 2011 - 11 Jun 2011)
  174. Mineral Bone Disorders & Parathyroidectomy, Sau Seng Lam Haemodialysis Workshop (Others) (22 May 2011 - 22 May 2011)
  175. Hypertension In Dialysis:New Ideas & New Chalenges, 27th Annual Congress of Malaysian Society of Nephrology , Malaysian Society of Nephrology  (National) (07 May 2011 - 07 May 2011)
  176. Infection Control in Dialysis Unit & Prevention in UTI , 9th APSIC Basic Training Course in Infection Control , Asian Pacific Society of Infection Control (National) (11 Apr 2011 - 22 Apr 2011)
  177. Diabetic Nephropathy, Novartis Training Workshop, Novartis (National) (20 Jan 2011 - 20 Jan 2011)
  178. Mineral Bone Disorder, MasterClass in Chronic Kidney Disease, UBM MEDICAL MALAYSIA (National) (31 Oct 2010 - 31 Oct 2010)
  179. Diagnosis & Staging in Chronic Kidney Disease, MasterClass in Chronic Kidney Disease, UBM MEDICAL MALAYSIA (National) (31 Oct 2010 - 31 Oct 2010)
  180. Patient selection & evaluation in ESRD, 200-hour Nephrology training workshop, MALAYSIAN SOCIETY OF NEPHROLOGY (National) (30 Oct 2010 - 31 Oct 2010)
  181. Treatment of minimal change disease in adults., Post-graduate course on Critical Care Nephrology & Glomerulonephritis, POST-GRADUATE RENAL SOCIETY OF MALAYSIA (National) (01 Oct 2010 - 02 Oct 2010)
  182. Update in Chronic Kidney Disease, Masterclass on Cardiometabolic & Renal Updates (National) (16 May 2010 - 16 May 2010)
  183. Renal Anaemia: Are all ESAs the same ?, 25th Malaysian Society of Nephrology Annual Seminar, Malaysian Society of Nephrology  (National) (23 Apr 2010 - 25 Apr 2010)
  184. Managing Catheter Sepsis, Kuala Lumpur Vascular Access Conference, VASCULAR SOCIETY OF MALAYSIA (National) (18 Mar 2010 - 19 Mar 2010)
  185. Non-pharmacological management of hypertension in dialysis patients., 7th Annual Dialysis Meeting, National Kidney Foundation (NKF), National Kidney Foundation (NKF) (National) (12 Dec 2009 - 13 Dec 2009)
  186. Kidney transplantation in diabetic patients, Malaysia Society of Transplantation, Malaysia Society of Transplantation (National) (31 Jul 2009 - 01 Aug 2009)
  187. Renal Transplantation:Malaysia perspective, Continuous Nursing Education, University Malaya Medical Centre (University) (16 Jul 2009 - 16 Jul 2009)
  188. Anticoagulation in continuous renal replacement therapy (CRRT), Continuous Renal Replacement Therapy (CRRT) WORKSHOP (University) (25 May 2008 - 25 May 2008)
  189. Clinical issues in treatment of acute renal failure, First UMMC International Nursing Congress, University Malaya Medical Centre (International) (29 Jun 2007 - 30 Jun 2007)
EVENT ORGANISER
  1. CKD Management: Timely RRT preparation, Short Course for CKD Educators 2016, Renal Division, UMMC (National) (22 Sep 2016 - 25 Sep 2016)
  2. Multidisciplinary Care in CKD, Short Course for CKD Educators 2016, Renal Division, UMMC (National) (22 Sep 2016 - 25 Sep 2016)
  3. Is it the end of calcium-based phosphate binder era?, 32nd Annual Congress of Malaysian Society of Nephrology 2016, Malaysian Society of Nephrology (National) (29 Apr 2016 - 01 May 2016)
  4. Use of RAS blockers in CKD - Anything new ?, 30th Annual Congress of Malaysian Society of Nephrology 2014. Kuala Lumpur. 21 June 2014., MALAYSIAN SOCIETY OF NEPHROLOGY (National) (21 Jun 2014 - 21 Jun 2014)
  5. Overview of Deceased Donor Transplantation in Malaysia, Workshop on Deceased Donor Transplant Coordination, UMMC RENAL DIVISION (University) (09 May 2014 - 09 May 2014)
  6. Managing advanced CKD in elderly - how far should we go?, UNIVERSITY MALAYA WORKSHOP SERIES, UMMC Renal Division (University) (23 Mar 2014 - 23 Mar 2014)
  7. 14th Congress of International Society of Peritoneal Dialysis (ISPD) Scientific Committee Member, 14th Congress of International Society of Peritoneal Dialysis (ISPD) , International Society of Peritoneal Dialysis (ISPD) & Malaysian Society of Nephrology (International) (09 Sep 2012 - 12 Sep 2012)
POSTER PRESENTER
  1. Creatinine and Cystatin-C Based Equations in Comparison with 51-Chromium EDTA in Prediction of Glomerular Filtration Rate in Malay Population in University Malaya Medical Centre, Renal week, American Society of Nephrology (ASN), American Society of Nephrology  (International) (30 Oct 2012 - 04 Nov 2012)
  2. Peritoneal Dialysis in Acute Renal Failure, 14th Congress of the International Society for Peritoneal Dialysis (ISPD), International Society for Peritoneal Dialysis  (International) (09 Sep 2012 - 12 Sep 2012)
  3. Self-care knowledge and compliance in patients undergoing peritoneal dialysis, 14th Congress of the International Society for Peritoneal Dialysis (ISPD). Kuala Lumpur. , International Society for Peritoneal Dialysis  (International) (09 Sep 2012 - 12 Sep 2012)
  4. A Comparison between Domestic Helper and Family Member assisted Peritoneal Dialysis, 14th Congress of the International Society for Peritoneal Dialysis (ISPD), International Society for Peritoneal Dialysis (International) (09 Sep 2012 - 12 Sep 2012)
  5. Exit Site Infection And Tunnel Infection: A Single Centre Experience., 14th Congress of the International Society for Peritoneal Dialysis (ISPD), International Society for Peritoneal Dialysis  (International) (09 Sep 2012 - 12 Sep 2012)
  6. Prevalence of Travelling Among Peritoneal Dialysis Patients in a Tertiary Healthcare Hospital in Malaysia, 14th Congress of the International Society for Peritoneal Dialysis (ISPD), International Society for Peritoneal Dialysis (International) (09 Sep 2012 - 12 Sep 2012)
  7. Utility of protocol biopsies in kidney transplantation. A single center experience., 15th Scientific Meeting of Malaysian Society of Transplantation, Malaysian Society of Transplantation (National) (17 May 2012 - 19 May 2012)
  8. CMV infection post renal transplant: The University Malaya Medical Centre (UMMC) experience., 15th Scientific Meeting of Malaysian Society of Transplantation, Malaysian Society of Transplantation (National) (17 May 2012 - 19 May 2012)
  9. Urine Neutrophil Gelatinase Associated Lipocalin Is Increased during Active Lupus Nephritis., Renal week, American Society of Nephrology (ASN) (International) (08 Nov 2011 - 13 Nov 2011)
  10. Transplant Tourism: Perspectives From A Country with a Low Transplant Rate., Congress of Asian Society of Transplantation (CAST) (International) (25 Sep 2011 - 28 Sep 2011)
  11. Conversion to mTORi from Calcineurin inhibitor in kidney transplant recipients, an UMMC experience., Congress of Asian Society of Transplantation (CAST) (International) (25 Sep 2011 - 28 Sep 2011)
  12. UTILITY OF ESTIMATED GLOMERULAR FILTRATION RATE IN LIVE KIDNEY DONORS, Congress of Asian Society of Transplantation (CAST) (International) (25 Sep 2011 - 28 Sep 2011)
  13. THE ROLE OF URINE NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN AS A BIOMARKER FOR LUPUS NEPHRITIS., 27th Annual Congress of Malaysian Society of Nephrology , Malaysian Society of Nephrology  (National) (06 May 2011 - 08 May 2011)
  14. HEALTH RELATED QUALITY OF LIFE OF ELDERLY PEOPLE WITH STAGE 5 CHRONIC KIDNEY DISEASE: HEMODIALYSIS VS NON-DIALYSIS TREATMENT , 27th Annual Congress of Malaysian Society of Nephrology , Malaysian Society of Nephrology  (National) (06 May 2011 - 08 May 2011)
  15. Usage of Herbal Medicine Among Malaysian Patients with Diabetes Mellitus and Hypertension, 27th Annual Congress of Malaysian Society of Nephrology , Malaysian Society of Nephrology  (National) (06 May 2011 - 08 May 2011)
  16. DIALYSIS RELATED SYMPTOMS AND THE EFFECT ON WELL BEING AMONG HEMODIALYSIS PATIENTS., 27th Annual Congress of Malaysian Society of Nephrology (National) (05 May 2011 - 08 May 2011)
  17. FLUID COMPLIANCE AMONG HEMODIALYSIS PATIENTS, 27th Annual Congress of Malaysian Society of Nephrology (National) (05 May 2011 - 08 May 2011)
  18. Hospital Usage among Chronic Hemodialysis Patients in a Tertiary Hospital. , Renal week, American Society of Nephrology (ASN) (International) (16 Nov 2010 - 21 Nov 2010)
  19. UTILITY OF ESTIMATED GLOMERULAR FILTRATION RATE IN LIVE KIDNEY DONORS. , Renal week, American Society of Nephrology (ASN). , American Society of Nephrology  (International) (16 Nov 2010 - 21 Nov 2010)
  20. NON FLUOROSCOPIC INSERTION OF TUNNELED HEMODIALYSIS CATHETER BY NEPHROLOGISTS. , Renal week, American Society of Nephrology (ASN) (International) (16 Nov 2010 - 21 Nov 2010)
  21. Prevalence of IF/TA in a Series of Kidney Transplant Biopsies. , Malaysian Society of Transplantation (National) (09 Jul 2010 - 11 Jul 2010)
  22. Kidney Transplant Biopsy Trends in a Single Center, Malaysian Society of Transplantation (National) (09 Jul 2010 - 11 Jul 2010)
  23. Early proliferative signal inhibitor (PSI) conversion with calcineurin-inhibitor withdrawal (CNI) improves renal allograft function and reduces the risk of developing proteinuria after conversion., Asian Pacific Congress of Nephrology (APCN) (International) (05 Jun 2010 - 08 Jun 2010)
  24. Early proliferative signal inhibitor (PSI) conversion with calcineurin-inhibitor withdrawal (CNI) improves renal allograft function and reduces the risk of developing proteinuria after conversion., 26th Malaysian Society of Nephrology Annual Seminar (National) (23 Apr 2010 - 25 Apr 2010)
  25. CLINICAL VALUE OF INCLUDING PERITONEAL CLEARANCE OF 2 MICROGLOBULIN IN THE ROUTINE ASSESSMENT OF PERITONEAL MEMBRANE TRANSPORTER STATUS., Renal week, American Society of Nephrology (ASN) (International) (27 Oct 2009 - 01 Nov 2009)
  26. Cross-sectional study of BK virus infection in kidney transplant recipients. A single centre experience., World Congress of Nephrology (WCN) and ERA-EDTA.  (International) (22 May 2009 - 26 May 2009)
  27. Epidemiology and impact of ethnicity on development of transplant associated hyperglycaemia in renal allograft recipients., World Congress of Nephrology (WCN) and ERA-EDTA (International) (22 May 2009 - 26 May 2009)
  28. Incidence, risk factors and outcome of AKI among ICU patients: Impact and value of RIFLE classification., World Congress of Nephrology (WCN) and ERA-EDTA (International) (22 May 2009 - 26 May 2009)
  29. Cross-sectional study of BK virus infection in kidney transplant recipients. A single centre experience. , XXII International Congress of The Transplantation Society. , International Society of Nephrology (International) (10 Aug 2008 - 14 Aug 2008)
  30. An uncommon cause of cord compression in patient on hemodialysis., ERA-EDTA XLV Congress (International) (10 May 2008 - 13 May 2008)
  31. Clinical characteristics and treatment outcome of membranous lupus nephritis , Asian Pacific Congress of Nephrology (APCN), Malaysian Society of Nephrology (International) (05 May 2008 - 08 May 2008)
  32. Metastatic spinal epidural abscess in hemodialysis patients: A case series of 6 patients., World Congress of Nephrology (WCN) (International) (21 Apr 2007 - 25 Apr 2007)
  33. Sexual transmission of hepatitis C in haemodialysis patients, Renal week, American Society of Nephrology (ASN), American Society of Nephrology  (International) (15 Nov 2006 - 19 Nov 2006)
  34. Short term catheter survival and complication rates following catheter insertion by peritoneoscope versus mini-laparotomy techniques., 22nd Malaysian Society of Nephrology Annual Seminar (National) (28 Apr 2006 - 30 Apr 2006)
PRESENTER
  1. A Comparison of Clinical Outcomes between Assisted and Self-Care Peritoneal Dialysis. A Single Center Experience., 14th Congress of the International Society for Peritoneal Dialysis (ISPD), International Society for Peritoneal Dialysis (International) (09 Sep 2012 - 12 Sep 2012)
  2. UTILITY OF ESTIMATED GLOMERULAR FILTRATION RATE IN LIVE KIDNEY DONORS. , Malaysian Society of Transplantation, Malaysian Society of Transplantation (National) (09 Jul 2010 - 11 Jul 2010)
  3. Risk of sexual transmission of hepatitis C in haemodialysis patients , 23nd Malaysian Society of Nephrology Annual Seminar, Malaysian Society of Nephrology  (National) (11 May 2007 - 13 May 2007)
  4. Long term outcome of patients with lupus nephritis following induction with intravenous cyclophosphamide , 22nd Malaysian Society of Nephrology Annual Seminar, Malaysian Society of Nephrology  (National) (28 Apr 2006 - 30 Apr 2006)
OTHERS
  1. Principles of management of renal anemia in pre-dialysis CKD and dialysis, Short Course on Renal Anemia and Its Management in Dialysis and pre-Dialysis CKD patients, UMMC Renal Team (International) (14 May 2016 - 15 May 2016)

ACADEMIC/PROF. SERVICES

Evaluation
  1. (2024) Panel Reviewer for The Umsc Ca.R.E Fund Research Grant(Umsc-Rg) & Dato' Mahmood Merican Medical Research Grant (Mmrg) 2024., University, (Reviewer)
  2. (2024) Umreg 2024 Panel Reviewer - Elucidating The Mechanism of Action of Mesenchymal Stem Cell-Derived Smallextracellular Vesicles (Msc-Sevs) in Spontaneously Hypertensive Rats Via Aorticprotein Expression and Profiling of Fecal and Serum Metabolites, University, (Reviewer)
  3. (2024) Mmedsc - Association Between Obesity and Kidney Outcomes: a Systematic Review and Meta-Analysis, University, (Internal Examiner)
  4. (2024) Reviewer of Cpg On Comprehensive Care in Advanced Kidney Disease, National, (External Evaluator)
  5. (2024) Mmc Nsr Evaluation Committee, National, (External Evaluator)
  6. (2023) Isn World Congress of Nephrology 2024 Abstract Reviewer, International, (Reviewer)
  7. (2023) Abstract Reviewer of 37th Annual Congress of Malaysian Society of Nephrology (Msn 2023), National, (Reviewer)
  8. (2023) Malaysian National Exit Examinations for Nephrology 2023, National, (External Examiner)
  9. (2023) Impact of Multi Component Integrated Care On Health Outcomes in Patients With Cardiorenal Metabolic Diseases, University, (Internal Examiner)
  10. (2022) Panel Reviewer for Department of Medicine Research Support Fund (Dom-Rsf) Cycle 3, 2022, University, (Reviewer)
  11. (2022) Examiner for UM Pre-Masterclass Workshop, University, (Internal Examiner)
  12. (2022) Judge Mdes Virtual Conference 2022 Poster Competition, National, (Reviewer)
  13. (2022) Panel Reviewer for Umsc Ca.R.E Fund (Research Grant) Cycle 1/2022, University, (Reviewer)
  14. (2022) Internal Examiner - Impact of Multicomponent Integrated Care On Clinical Outcomes in Patients With Type 2 Diabetes, University, (Internal Examiner)
  15. (2022) Internal Examiner - Impact of Multicomponent Integrated Care On Clinical Outcomes in Patients With Type 2 Diabetes, University, (Internal Examiner)
  16. (2022) Mmc Nsr Evaluation Committee, National, (External Evaluator)
  17. (2021) Kidney Disease Cohort (Kiddico) of Southern Denmark; Design, Coverage, Generalizability and Implications for Use., International, (Reviewer)
  18. (2021) Ummp Undergraduate Interviewer, University, (Internal Assessor)
  19. (2021) Congress of Asian Pacific of Transplantation (Cast) Abstract Reviewer, International, (Reviewer)
  20. (2021) Mmed Part 2 Clinical Examination, University, (Internal Examiner)
  21. (2021) Malaysia Toray Science Foundation (Mtsf) Grant Reviewer, National, (Reviewer)
  22. (2021) Malaysia Nephrology Board Examination, National, (Internal Examiner)
  23. (2021) Examiner for Master of Medical Science (Research), University, (Internal Examiner)
  24. (2021) Optimization of Early Diagnosis of Diabetic Kidney Disease With Targeted Metabolomics, International, (Reviewer)
  25. (2021) Hcv Core Antigen Plays An Important Role in The Fight Against Hcv as An Alternative to Hcv-Rna Detection, International, (Reviewer)
  26. (2021) 17th Congress of Asian Society of Transplantation (CAST) Abstract Reviewer, (Reviewer)
  27. (2021) Malaysia Toray Science Foundation (MTSF) Grant Reviewer, (Reviewer)
  28. (2020) Journal of Clinical Laboratory Analysis "HCV core antigen plays an important role in the fight against HCV as an alternative to HCV-RNA detection.", (Reviewer)
  29. (2020) MALAYSIAN SOCIETY OF NEHROLOGY BOARD EXAMINATION 2020, (External Examiner)
  30. (2020) NEPHROLOGY JOURNAL "Research on the hepcidin level and influence factors of renal anemia in chronic kidney disease.", (Reviewer)
  31. (2020) RENAL FAILURE JOURNAL "Diagnostic value of TWEAK for predicting active lupus nephritis in patients with systemic lupus erythematosus: a systematic review and meta-analysis", (Reviewer)
  32. (2020) PLOSONE JOURNAL "Clinical utility of hepatitis C virus core antigen (HCVcAg) assay to identify active HCV infection in chronic kidney disease patients.", (Reviewer)
  33. (2020) MALAYSIAN FAMILY PHYSICIAN JOURNAL "A Practical Approach to Chronic Kidney Disease in Primary Care", (Reviewer)
  34. (2019) Master of Medicine(MMED) Thesis: Vitamin-K Status In Diabetic Patients With Chronic Kidney Disease Stage 3-5 And Its Effects On Chronic Kidney Disease Mineral Bone Disorder, (External Examiner)
  35. (2019) PhD Thesis(Nursing): Exploring end of life care preferences among individual's living with chronic heamodialys is treatment using Q methodology, (Internal Examiner)
  36. (2019) PhD Thesis: DIETARY BURDEN ON INFLAMMATION IN END STAGE KIDNEY DISEASE PATIENTS ON MAINTENANCE HEMODIALYSIS., (External Examiner)
  37. (2019) RENAL FAILURE JOURNAL Efficacy and safety of rituximab as an induction therapy for lupus nephritis: a metaanalysis , (Reviewer)
  38. (2019) MALAYSIAN SOCIETY OF NEHROLOGY BOARD EXAMINATION 2019, (External Examiner)
  39. (2019) Journal of Clinical and Translational Nephrology (JCTN) DOUBLE POSITIVE ANTIGBM AND ANCA ASSOCIATED GLOMERULONEPHRITIS- A CASE REPORT , (Reviewer)
  40. (2019) 17th Congress of the Asian Society of Transplantation (CAST 2021) SCIENTIFIC COMMITTEE, (Scientific Committee)
  41. (2019) Journal of Clinical and Translational Nephrology (JCTN) Co-Editor, (Editor)
  42. (2019) NEPHROLOGY JOURNAL "Clinical, Pathological Characteristics and Outcomes of IgA Nephropathy Patients with different ages.", (Reviewer)
  43. (2018) The Potential Implications of Presumed Consent System on Organ Donation & Transplant in Malaysia, (Reviewer)
  44. (2018) MALAYSIAN SOCIETY OF NEPHROLOGY BOARD EXAMINATION , (Internal Examiner)
  45. (2018) WORLD CONGRESS OF NEPHROLGY 2019 , (Reviewer)
  46. (2018) Malaysian Journal of Medicine & Health Sciences "PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND MINIMAL CHANGE DISEASE AS ONE SPECTRUM OF DISEASE." , (Reviewer)
  47. (2016) Proceedings of Singapore Healthcare, (Reviewer)
  48. (2016) National Nephrology Board Examination Examiner, (External Examiner)
  49. (2014) Urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL) And Monocyte Chemoattractant Protein-1(uMCP-1) As Biomarkers of Renal Disease Activity in Lupus Nephritis., (External Examiner)
  50. (2014) Carotid Intima Media Thickness Among Kidney Transplant Recipients In UKMMC, (External Examiner)
  51. (2014) Nephrology Board Examination 2014, (External Examiner)
  52. (2013) Anti-proteinuric Effect of Aliskiren Versus Losartan in Primary Glomerulonephritis , (External Examiner)
  53. (2012) Reviewer for International Society of Peritoneal Dialysis (ISPD) Abstracts, (Reviewer)
  54. (2011) Efficacy of Saxagliptin as add-on therapy to Insulin compared to Insulin therapy alone in Regular Haemodialysis Patients with Type 2 Diabetes Mellitus , (External Examiner)
  55. (2011) Oral paricalcitol versus oral calcitriol for the treatment of secondary hyperparathyroidism in ESRD patients on CAPD., (External Examiner)
  56. (2008) RENAL ANGIOMYOLIPOMAS IN UMMC: IT S SPECTRUM OF PRESENTATION AND MANAGEMENT, (Reviewer)
Contribution to external organisation
  1. (2024) Apsn Clinical Practice Guideline On Diabetic Kidney Disease Update, International, (Expert Advisor)
  2. (2024) National Lead Principal Investigator for Stabilize-Ckd Study, International, (Expert Advisor)
  3. (2024) National Renal Registry Research and Publication Committee 2022 - 2024, National, (Technical Advisor)
  4. (2024) National Renal Registry Advisory Committee 2022 - 2024, National, (Expert Advisor)
  5. (2024) Chairman of The Malaysian Society of Nephrology Research Grant Committee 2022 - 2024, National, (Expert Advisor)
  6. (2023) Paired Kidney Exchange Action Committee, National, (Expert Advisor)
  7. (2023) Paired Kidney Exchange Action Committee, National, (Expert Advisor)
  8. (2022) Malaysia Kidney Allocation System (Mykas) Committee, National, (Expert Advisor)
  9. (2021) International Virtual Advisory Board Meeting, International, (Expert Advisor)
  10. (2021) Dulaglutide Advisory Board, National, (Expert Advisor)
  11. (2021) Msqh Standards Development Workgroup, National, (Expert Advisor)
  12. (2021) Ketosteril Advisory Board Meeting, National, (Expert Advisor)
  13. (2021) University Malaya Specialist Centre Consultant Nephrologist, University, (Visiting clinical specialists)
  14. (2020) APSN HIF-PH inhibitor Recommendation Committee, Asian Pacific Society of Nephrology (APSN)
  15. (2019) Asian Pacific Society of Nephrology(APSN) DM Nephropathy Clinical Practice Guidelines Workgroup, Asian Pacific Society of Nephrology(APSN)
  16. (2019) Taskforce to Update the 2015 CPG for management of T2DM (5th edition), Malaysian Endocrine & Metabolic Society
  17. (2018) Curriculum Setting for Renal Post-basic Nursing Course, University Malaya Medical Centre
  18. (2017) Hypertension CPG Development Workgroup, Malaysian Society of Hypertension
  19. (2015) Chronic Kidney Disease Clinical Practice Guidelines (CPG) Development Group, Malaysian Society of Nephrology
  20. (2015) "Hemodialysis Quality & Standards" Update Working Committee, Malaysian Society of Nephrology
Contribution to event
  1. (2021) Diabetes Expert Input Forum Panelist, National, (Panelist/Moderator)
  2. (2021) Heart Failure Global Conclave Panelist, National, (Panelist/Moderator)
Media appearance
  1. (2022) Low Kidney Transplantation Rate in Malaysia - China Press, National, (Interview)
  2. (2022) Kidney Disease Importance of Self Efficacy & Self-Management - Sinchew Daily, National, (Interview)
  3. (2022) Pemindahan Buah Pinggang Lebih Baik Daripada Rawatan Dialisis? - Utusan Malaysia, National, (Interview)
  4. (2022) Pros and Cons of Getting a Kidney Transplant_health Matters, National, (Interview)
  5. (2022) Pros and Cons of Getting a Kidney Transplant, National, (Interview)
  6. (2022) Kidney Transplant Explained - Daily Straits, National, (Interview)

SUPERVISION

Under Graduate Students
  1. (2024) Worsening Kidney Function in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Retrospective Observational Cohort Study in a Multi-Ethnic Tertiary Centre in Malaysia
  2. (2024) Prognostic factors for survival after CABG surgery: A retrospective study
  3. (2024) Prevalence of Pre- and Post-Treatment Renal Disorders in Cancer Patients on Targeted Agents or Immunotherapy: A Retrospective Observational Cohort Study in a Multi-Ethnic Tertiary Centre in Malaysia
  4. (2024) Prevalence of Pre and Post-treatment Renal Disorders in Cancer Patients on Pembrolizumab: A Retrospective Observational Cohort Study in multi-ethnic Tertiary Centre in Malaysia
  5. (2024) Prevalence of Pre and Post-treatment Renal disorders in Cancer Patients on Immunotherapy: A Retrospective Observational Cohort Study in a Multi-Ethnic Tertiary Centre in Malaysia
  6. (2024) Incidence, Risk Factors and Outcomes of Acute Kidney Injury in Hospitalised Heart Failure Patients: A Single Centre, Retrospective Study
  7. (2024) Incidence of CMV & BKV Infection in Kidney Transplant Recipients
  8. (2024) Clinical Registry of Systemic Lupus Erythematosus (SLE) Patients with High anti-double-stranded DNA (dsDNA) levels in UMMC
  9. (2024) Chronic Kidney Disease progression after CABG surgery: Incidence & associated factors
  10. (2024) AKI POST-CABG SURGERY: INCIDENCE AND ASSOCIATED FACTORS
  11. (2014) Practice Pattern in Diabetic Management at Tertiary Care Settings
  12. (2013) Prevalence of Chronic Kidney Disease among Hypertensive Elderly
  13. (2013) Chronic Kidney Disease: Perceived Knowledge among CKD Patients
  14. (2013) Chronic Kidney Disease: Illness Perception, Attitude and Pill Burden of Pre-dialysis Patient and Its Association with Medication Adherence
  15. (2011) Elective Project: Prevalence of Inter-arm Blood Pressure Difference among Patients with Chronic Kidney Disease.
  16. (2011) Elective Project: Pre-dialysis Care Among newly diagnosed ESRD
  17. (2011) Elective Project: Contraceptive counseling and use among patients with systemic lupus erythematosus (SLE)
  18. (2011) Elective Project: Attitudes & knowledge with regard to organ donation among medical students
  19. (2010) Elective Project: Usage of Herbal Medicine Among Patients Attending Diabetic & Hypertension Clinic At UMMC
  20. (2010) Elective Project: Frequency, severity and distress of Dialysis related symptoms among haemodialysis patients.
Postgraduate Student
PhD/ Doctoral
  1. (2024) Clinical and Genetics factors Associated with Mycophenolic Acid Treatment in Patients with Lupus Nephritis in Malaysia, ESRA NASRALDIN KHALIL SHARAFALDIN
  2. (2022) CLINICAL AND GENETIC MARKERS ASSOCIATED WITH ERYTHROPOIETIN DEFICIENCY ANAEMIA AND ERYTHROPOETIN STIMULATING AGENT TREATMENT RESPONSE IN PRE-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS, NAVA YUGAVATHY A/P SELVARAJA
  3. (2021) FACTORS ASSOCIATED WITH FATIGUE AMONG PEOPLE WITH KIDNEY FAILURE DURING THE FIRST SIX MONTHS OF INITIATING HAEMODIALYSIS IN SRI LANKA, THALWATHTHE GEDARA NADEEKA SHAYAMALIE GUNARATHNE
  4. (2020) Development of a CKDu Prevelence Prediction Tool to Identify CKDu Endemic Areas to Enhance Public Health Awareness in Sri Lanka, THALWATHTHE GEDARA NADEEKA SHAYAMALIE GUNARATHNE
  5. (2020) Clinical and Genetic Marker of EPO deficiency anemia in Chronic Kidney Disease (pre-dialysis) Patients, NAVA YUGAVATHY A/P SELVARAJA
  6. (2019) Generation of single chain fragment variable antibody against CD80 protein for minimal change disease, Teh Yoong Mond (M0100105)
  7. (2019) Effectiveness of Chronic Kidney Disease Nurse-led Self-management Intervention Program (CKD-NLSM): A Randomized Controlled Trial, AL SAWAD AYAT
  8. (2019) ACCESS TO RENAL TRANSPLANTATION AND POST TRANSPLANTATION PROGNOSIS (ReTRAPP) STUDY OF ADULTS IN MALAYSIA., PETER GAN KIM SOON
  9. (2017) CHARACTERIZATION OF PATHOGENIC HLA AND NON-HLA ANTIBODIES IN RENAL TRANSPLANT RECIPIENTS., RHANYE MAC GUAD
  10. (2017) ACCESS TO RENAL TRANSPLANTATION AND POST-TRANSPLANTATION PROGNOSIS (ReTRAPP) STUDY OF ADULTS IN MALAYSIA, PETER GAN KIM SOON
  11. (2016) Association of Clinical Genetic Markers with Erythropoietin Deficiency Anemia., NURUL AIN AQILAH BINTI MOHD ZIN
  12. (2015) Association of Clinical Genetic Markers with Erythropoietin Deficiency Anemia., NURUL AIN AQILAH BINTI MOHD ZIN
  13. (2014) Effect of Predialysis Education on Progression of Disease Among Chronic Kidney Disease Patients, SURINDAR KAUR A/P SURAT SINGH
  14. (2009) Molecular Pathology of Systemic Lupus Erythematosus in Asians, Chai Hwa Chia
  15. (2009) Fluid compliance among hemodialysis patients, Tang Li Yoong
  16. (2008) THE EFFECT OF PATIENT EDUCATION ON FLUID COMPLIANCE AMONG HAEMODIALYSIS PATIENTS, TANG LI YOONG
Master
  1. (2024) Molecular Insights into the Effects of Dihydrotanshinone I (DHTS) on the Pathogenesis of Autosomal Dominant Polycystic Kidney Disease (ADPKD), RHUBANIYA MAHENDRAN
  2. (2024) Unveiling the Burden of Catheter Related Blood Stream Infections in Haemodialysis Patients; An Inadept Analysis of Prevalence, Risk Factors, Treatment Outcomes and Economic Impact, VINCENT MARSHALL MARIADASS
  3. (2022) Prevalence of Proteinuria and Metabolic Acidosis among Kidney Transplant Recipients and the Impact of Dietary Intervention, LAU WAI POOI
  4. (2022) Metabolic-Dysfunction-Associated Fatty Liver Disease (MAFLD) and Advanced Liver Fibrosis Among Hemodialysis Patients in a Multiracial Urban Population in Malaysia, WONG WEI KEI
  5. (2021) MEDICATION ADHERENCE, MEDICATION BURDEN, DRUG-RELATED PROBLEMS AND QUALITY OF LIFE IN PATIENTS WITH END STAGE RENAL DISEASE IN MALAYSIA, KENT GOH KA KIAN
  6. (2020) UTILIZATION OF HCV CORE ANTIGEN IN HEMODIALYSIS PATIENTS TO IDENTIFY PATIENTS ELIGIBLE FOR HCV TREATMENT, WONG XUE ZHENG
  7. (2020) Proteinuria & metabolic acidosis among renal transplant recipients - the impact of dietary intervention, Wai Pooi Lau
  8. (2020) Non-albuminuric Diabetic Kidney Disease: Prevalence, Clinical Characteristic and Progression of Kidney Disease, Jansee Rani a/p Pitchamuthu
  9. (2020) Metabolic-associated Fatty Liver Disease (MAFLD) and Advanced Liver Fibrosis among Hemodialysis Patients in Malaysia, Wong Wei Kei
  10. (2020) Elucidate the anti-proliferative role of 15,16-DHTS in autosomal dominant polycystic kidney disease, Rhubaniya Mahendran
  11. (2020) ADHERENCE, PILL BURDEN, QUALITY OF LIFE AND PHARMACEUTICAL CARE ISSUES ENCOUNTERED IN PATIENTS WITH END STAGE RENAL DISEASE, KENT GOH KA KIAN
  12. (2020) UTILIZATION OF HCV CORE ANTIGEN IN HEMODIALYSIS PATIENTS TO IDENTIFY PATIENTS ELIGIBLE FOR HCV TREATMENT, WONG XUE ZHENG
  13. (2019) THE INCIDENCE AND OUTCOME OF HOSPITAL ACQUIRED ACUTE KIDNEY INJURY IN UMMC, THEEBA TINAKARUN
  14. (2019) Prevalence and Predictors of Nosocomial Infections among End Stage Renal Disease(ESRD) Patients, Saad Hanif Abbasi
  15. (2017) RENAL AND CARDIOVASCULAR OUTCOMES AMONGST DIABETIC PATIENTS WITHCHRONIC KIDNEY DISEASE AND CORONARY ARTERY CALCIFICATION: A FOLLOW-UP STUDY, CHENG SHIAN FENG
  16. (2017) CHARACTERISTIC AND CLINICAL OUTCOMES OF FRAILTY IN PERITONEAL DIALYSIS PATIENTS IN A TERTIARY CENTER, KHOR HOW KIAT
  17. (2017) A Retrospective Study: Comparing Efficacy of Cyclophosphamide to Mycophenolate Mofetil as an Induction Agent for Patients with Lupus Nephritis, Nur Aishah binti Ab. Wahid
  18. (2017) ADHERENCE, PILL BURDEN, QUALITY OF LIFE AND PHARMACEUTICAL CARE ISSUES ENCOUNTERED IN PATIENTS WITH END STAGE RENAL DISEASE, KENT GOH KA KIAN
  19. (2015) Dietary Sodium Restriction in the Malaysian CKD population:Are we doing enough?, Sumathi Raju
  20. (2015) Biopsy-proven diabetic nephropathy: The histopathological classification and its clinical implications, LIM YIK SHEN
  21. (2015) Association between serum 25-hydroxyvitamin D levels and carotid atherosclerosis in chronic kidney disease patients, NG YONG MUH
  22. (2015) ASSOCIATION BETWEEN MALNUTRITION INFLAMMATION SCORE AND PERITONEAL DIALYSIS RELATED INFECTIONS, SITI FATIMAH BINTI KHALID
  23. (2014) Urinary Free Light Chain as a Potential Biomarker for Lupus Nephritis in UMMC, Lee Yee Wan
  24. (2014) RENAL AND CARDIOVASCULAR OUTCOMES AMONGST DIABETIC PATIENTS WITH CHRONIC KIDNEY DISEASE AND CORONARY ARTERY CALCIFICATION: A FOLLOW-UP STUDY, CHENG SHIAN FENG
  25. (2014) FRAILTY AS A PREDICTOR OF ADVERSE OUTCOME IN PERITONEAL DIALYSIS PATIENTS IN A TERTIARY CENTER, KHOR HOW KIAT
  26. (2013) A STUDY OF THE EFFECTS OF COOL DIALYSIS ON BLOOD PRESSURE FLUCTUATIONS IN MALAYSIA., Ali Cadersa
  27. (2013) ASSESSMENT OF GLYCEMIC CONTROL IN PATIENTS WITH DIABETES MELLITUS ON HAEMODIALYSIS USING GLYCATED ALBUMIN AND HBA1C, Dr Shahnon Anuar bin Shahrani
  28. (2012) PERCUTANEOUS ANGIOPLASTY OF HEMODIALYSIS FISTULAS: FACTORS CONTRIBUTING TO EARLY RESTENOSIS POST INTERVENTION, Dr Teo Yee Shean
  29. (2011) CORRELATION OF PLAIN RADIOGRAPHS AND CORONARY ARTERY COMPUTED TOMOGRAPHY TO DETECT VASCULAR CALCIFICATION IN PRE DIALYSIS DIABETIC PATIENTS WITH CHRONIC KIDNEY DISEASE., Dr. Sumitha A/P S. Balasingam
  30. (2010) Racial factors in Lupus Nephritis, Dr. Sheriza Izwa bt Zainuddin
  31. (2010) Quality of Life of Elderly people with Renal Failure: Comparing those on haemodialysis to medical therapy, Dr. Alan Ch ng Swee Hock
  32. (2008) Cardiovascular disease among ESRD patients, DR. SIVARANI A/P R.M. SATHASIVAM

TEACHING

Master
  1. (2021) NA - Mmed
  2. (2012) Approach to Renal Biopsy
  3. (2012) Kidney Disease & Pregnancy
  4. (2012) Overview of Renal Biopsy
  5. (2011) Chronic Kidney Disease
  6. (2011) Principles of Dialysis
  7. (2010) Acid Base Disorders & Electrolyte Imbalance
  8. (2010) Lupus Nephritis
  9. (2010) Master Part 2 Revision Course
  10. (2010) Lupus Nephritis
  11. (2009) Master Part 1 Revision Course
  12. (2009) Mmed Part 2 Revision Course
  13. (2009) Overview of Renal Biopsy
  14. (2008) Mechanism of Acute Renal Failure
Bachelor
  1. (2021) MIA 2001 - Universiti Malaya Medical Programme (Ummp) Stage 2
  2. (2021) MIA2001 - Universiti Malaya Medical Programme (Ummp) Stage 3.1
  3. (2021) NAMIA2001 - Universiti Malaya Medical Programme (Ummp) Stage 3.3
  4. (2020) UMMP - Introduction to Renal Transplantation
  5. (2020) UMMP - Introduction to Renal Transplantation
  6. (2020) UMMP - Lupus Nephritis
  7. (2020) UMMP - Seminar in Glomerulonephritis
  8. (2019) UMMP - End Stage Renal Disease - Renal Replacement Therapy
  9. (2019) UMMP - Glomerulonephritis
  10. (2019) UMMP - Lupus Nephritis
  11. (2018) MBBS - Transplantation & Hla
  12. (2018) UMMP - Introduction to Renal Transplantation
  13. (2018) UMMP - Lupus Nephritis
  14. (2018) UMMP - Glomerulonephritis
  15. (2017) UMMP2016 - Introduction to Renal Transplantation
  16. (2016) UG2016 - Transplantation & Hla
  17. (2016) UMMP2015 - Introduction to Renal Transplantation
  18. (2016) UMMP2015 - Lupus Nephritis
  19. (2016) UMMP2016 - Lupus Nephritis
  20. (2016) UMMP2016 - Seminar in Glomerulonephritis
  21. (2014) Transplantation & Hla
  22. (2012) Transplantation & Hla
  23. (2010) Hla & Renal Transplantation
  24. (2009) Acid Base Disorders
  25. (2009) Management of Poisoning.
  26. (2009) Symptoms & Signs of Renal Diseases.
  27. (2009) Glomerular Disease and Nephrotic Syndrome
  28. (2009) Introduction to Haemodialysis.
  29. (2008) Introduction to Haemodialysis.
  30. (2007) Drugs in Renal Failure
  31. (2007) Glomerular Disease and Nephrotic Syndrome
  32. (2007) Introduction to Haemodialysis.
  33. (2007) Management of Poisoning.
  34. (2007) Symptoms and Signs of Renal Diseases
  35. (2006) Symptoms and Signs of Renal Disease
Others
  1. (2012) Anticoagulatiuon in Hemodialysis
  2. (2012) Renal Anaemia in Chronic Kidney Disease and Dialysis Patients
  3. (2012) Renal Anemia in Ckd and Dialysis Patients
  4. (2012) Renal Transplantation for Critical Care Nursing
  5. (2012) Overview of Renal Transplantation
  6. (2010) Systemic Disease Affecting The Kidneys
  7. (2010) Management of Patient Post-Renal Transplantation
  8. (2010) Overview of Renal Transplantation
  9. (2009) Renal Transplantation for Critical Care Nursing
  10. (2021) - - Program Sijil Perawatan Renal (Post-Basic Renal Nursing Course)

SOCIAL RESPONSIBILITY ACTIVITIES

  • Public Talk On Chronic Kidney Disease, (17 Mar 2024 - 17 Mar 2024) (National)
  • Public Talk On Treatment for Managing Kidney Disease &Amp; Ensuring Wellness, (07 Jan 2024 - 07 Jan 2024) (National)
  • Public Talk On Chronic Kidney Disease, (11 Apr 2021 - 11 Apr 2021) (National)
  • Member of The National Renal Registry Advisory Committee, (10 Dec 2020 - 10 Dec 2022)
  • Chairperson of The National Renal Registry Research and Publication Committee, (10 Dec 2020 - 10 Dec 2022)
  • National Kidney Foundation(Nkf) Dialysis Committee Chair, (01 Nov 2020 - 31 Oct 2022)
  • National Kidney Foundation(Nkf) Board of Director, (01 Oct 2020 - 30 Sep 2022)
  • Chairman of The Malaysian Society of Nephrology Research Committee 2020 - 2022, (25 Aug 2020 - 25 Aug 2022)
  • Council Member Malaysian Society of Nephrology 2020 - 2022, (25 Jul 2020 - 25 Jul 2022)
  • Public Talk On "Chronic Kidney Disease - Early Detection & Management", (22 Feb 2020 - 22 Feb 2020)
  • Malaysia Kidney Allocation System (Mykas) Committee Member, (01 Jan 2020 - 31 Dec 2022)
  • Ckd Short Course for Nurses 2019, (25 Aug 2019 - 25 Aug 2019)
  • Ahli Jawatankuasa Kerja Ubat-Ubatan Urologi dan Nefrologi, Kkm, (01 Aug 2019 - 31 Jul 2020)
  • Revise Nephrology 2019, (27 Jul 2019 - 28 Jul 2019)
  • Hemodialysis Workshop for Dialysis Nurses, (07 Apr 2019 - 07 Apr 2019)
  • Old Kidneys Masterclass 2019, (31 Mar 2019 - 31 Mar 2019)
  • Public Talk On "Diet Management Among Patients On Dialysis", (24 Mar 2019 - 24 Mar 2019)
  • Public Talk On "Chronic Kidney Disease", (17 Mar 2019 - 17 Mar 2019)
  • National Specialist Register(Nsr) Evaluation Committee, (19 Feb 2019 - 18 Feb 2021)
  • Malaysian Society of Nephrology(Msn) Council Member 2018-2020, (28 Jul 2018 - 13 Jun 2020)
  • Malaysian Society of Transplantation(Mst) Council 2018-2020, (05 May 2018 - 11 Apr 2020)
  • Public Talk On "Kidneys & Women'S Health", (11 Mar 2018 - 11 Mar 2018)
  • Public Talk On "Chronic Kidney Disease & Obesity" During World Kidney Day 2017, (12 Mar 2017 - 12 Mar 2017)
  • Public Talk On "Chronic Kidney Disease", (12 Nov 2016 - 12 Nov 2016)
  • Electronic Malaysian Organ Sharing System (Emoss) Committee Member 2016-2018, (04 Aug 2016 - 30 Sep 2020)
  • Council Member of Malaysian Society of Nephrology 2016-2018, (30 Apr 2016 - 30 Apr 2018)
  • Msn Research Grant Review Committee Chair, (05 Jan 2016 - 05 Jan 2018)
  • Nsr Nephrology Specialist Subcommittee 2016-2018, (04 Jan 2016 - 04 Jan 2018)
  • Ckd Cpg Development Group Panel, (09 Dec 2015 - 09 Dec 2017)
  • National Kidney Foundation (Nkf) Dialysis Committee Member, (28 Sep 2015 - 28 Sep 2020)
  • Public Talk On "Chronic Kidney Disease", (13 Jun 2015 - 13 Jun 2015)
  • Public Talk On ‘Myths & Facts About Chronic Kidney Disease’, (15 Mar 2015 - 15 Mar 2015)
  • Malaysian Society of Nephrology Chairman of Cme Committee, (11 Jul 2014 - 11 Jul 2016)
  • Malaysian Society of Nephrology Secretary, (11 Jul 2014 - 11 Jul 2014)
  • National Credentialing Committee (Nephrology Sub-Committee), (04 Jan 2014 - 04 Jan 2016)
  • Committee Member for Malaysian Registry of Renal Biopsy (Mrrb), (28 Dec 2012 - 28 Dec 2014)
  • Council Member for Malaysian Society of Nephrology, (10 Sep 2012 - 10 Sep 2014)
  • National Credentialing Committee - Specialty Subcommittee for Nephrology, (04 Jan 2012 - 03 Jan 2014)
  • Msqh Drafting Committee of Hemodialysis Service Accreditation Standards, (03 Jan 2012 - 03 Jan 2013)
  • Electronic Malaysian Organ Sharing System (Emoss) Review Committee, (17 Nov 2011 - 17 Nov 2012)
  • 18th Mdtr Report Expert Panel, (11 Feb 2011 - 11 Feb 2012)
  • Committee Member of National Organ & Tissue Transplantation Policy Revision Committee, (01 Sep 2010 - 01 Sep 2011)
  • Committee Member for Malaysian Registry of Renal Biopsy (Mrrb), (20 Jul 2010 - 20 Jul 2012)
  • Council Member for Malaysian Society of Nephrology (Msn), (24 Jun 2010 - 24 Jun 2012)
  • Expert Panel of National Transplant Registry, (31 May 2010 - 31 May 2011)
  • International Society of Peritoneal Dialysis (Ispd) Organizing Committee, (01 Mar 2010 - 01 Oct 2012)
  • Council Member for Malaysian Society of Nephrology, (19 May 2009 - 19 May 2010)